avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Elf1
|
ENSMUSG00000036461.17 | Elf1 |
Elf2
|
ENSMUSG00000037174.19 | Elf2 |
Etv2
|
ENSMUSG00000006311.9 | Etv2 |
Elf4
|
ENSMUSG00000031103.13 | Elf4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Elf4 | mm39_v1_chrX_-_47543029_47543071 | 0.93 | 2.2e-16 | Click! |
Elf2 | mm39_v1_chr3_-_51248032_51248130 | 0.84 | 1.7e-10 | Click! |
Elf1 | mm39_v1_chr14_+_79753055_79753148 | 0.54 | 6.3e-04 | Click! |
Etv2 | mm39_v1_chr7_-_30335277_30335277 | 0.32 | 5.7e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_90603013 | 52.78 |
ENSMUST00000069960.12
ENSMUST00000117167.2 |
S100a9
|
S100 calcium binding protein A9 (calgranulin B) |
chr11_+_87684299 | 46.33 |
ENSMUST00000020779.11
|
Mpo
|
myeloperoxidase |
chr16_-_18630722 | 41.47 |
ENSMUST00000000028.14
ENSMUST00000115585.2 |
Cdc45
|
cell division cycle 45 |
chr11_+_87684548 | 40.34 |
ENSMUST00000143021.9
|
Mpo
|
myeloperoxidase |
chr19_-_9876815 | 40.16 |
ENSMUST00000237147.2
ENSMUST00000025562.9 |
Incenp
|
inner centromere protein |
chr5_+_90920294 | 36.34 |
ENSMUST00000031320.8
|
Pf4
|
platelet factor 4 |
chr2_+_91480460 | 33.95 |
ENSMUST00000111331.9
|
Arhgap1
|
Rho GTPase activating protein 1 |
chr7_-_126641593 | 33.05 |
ENSMUST00000032915.8
|
Kif22
|
kinesin family member 22 |
chr1_-_132318039 | 32.38 |
ENSMUST00000132435.2
|
Tmcc2
|
transmembrane and coiled-coil domains 2 |
chr6_-_125168637 | 32.14 |
ENSMUST00000043848.11
|
Ncapd2
|
non-SMC condensin I complex, subunit D2 |
chr1_-_173161069 | 32.10 |
ENSMUST00000038227.6
|
Ackr1
|
atypical chemokine receptor 1 (Duffy blood group) |
chr2_-_25911544 | 31.63 |
ENSMUST00000136750.3
|
Ubac1
|
ubiquitin associated domain containing 1 |
chr7_-_24459736 | 30.84 |
ENSMUST00000063956.7
|
Cd177
|
CD177 antigen |
chr2_+_91480513 | 30.65 |
ENSMUST00000090614.11
|
Arhgap1
|
Rho GTPase activating protein 1 |
chr11_+_70529944 | 30.43 |
ENSMUST00000055184.7
ENSMUST00000108551.3 |
Gp1ba
|
glycoprotein 1b, alpha polypeptide |
chr11_+_72851989 | 28.94 |
ENSMUST00000163326.8
ENSMUST00000108485.9 ENSMUST00000021142.8 ENSMUST00000108486.8 ENSMUST00000108484.8 |
Atp2a3
|
ATPase, Ca++ transporting, ubiquitous |
chr9_-_20864096 | 28.90 |
ENSMUST00000004202.17
|
Dnmt1
|
DNA methyltransferase (cytosine-5) 1 |
chr15_-_54953819 | 28.68 |
ENSMUST00000110231.2
ENSMUST00000023059.13 |
Dscc1
|
DNA replication and sister chromatid cohesion 1 |
chr3_-_89325594 | 28.54 |
ENSMUST00000029679.4
|
Cks1b
|
CDC28 protein kinase 1b |
chr2_-_25911691 | 28.03 |
ENSMUST00000036509.14
|
Ubac1
|
ubiquitin associated domain containing 1 |
chr5_+_90920353 | 27.89 |
ENSMUST00000202625.2
|
Pf4
|
platelet factor 4 |
chr9_-_57743989 | 27.76 |
ENSMUST00000164010.8
ENSMUST00000171444.8 ENSMUST00000098686.4 |
Arid3b
|
AT rich interactive domain 3B (BRIGHT-like) |
chr3_+_10077608 | 27.76 |
ENSMUST00000029046.9
|
Fabp5
|
fatty acid binding protein 5, epidermal |
chr19_+_6135013 | 27.14 |
ENSMUST00000025704.3
|
Cdca5
|
cell division cycle associated 5 |
chr10_-_117628565 | 26.20 |
ENSMUST00000167943.8
ENSMUST00000064848.7 |
Nup107
|
nucleoporin 107 |
chr19_-_6996791 | 25.33 |
ENSMUST00000040772.9
|
Fermt3
|
fermitin family member 3 |
chr7_-_126641565 | 24.71 |
ENSMUST00000205806.2
|
Kif22
|
kinesin family member 22 |
chr8_+_73488496 | 24.70 |
ENSMUST00000058099.9
|
F2rl3
|
coagulation factor II (thrombin) receptor-like 3 |
chr11_-_102360664 | 24.52 |
ENSMUST00000103086.4
|
Itga2b
|
integrin alpha 2b |
chr7_+_24069680 | 24.01 |
ENSMUST00000205428.2
ENSMUST00000171904.3 ENSMUST00000205626.2 |
Kcnn4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
chr19_-_10181243 | 23.89 |
ENSMUST00000142241.2
ENSMUST00000116542.9 ENSMUST00000025651.6 ENSMUST00000156291.2 |
Fen1
|
flap structure specific endonuclease 1 |
chr1_+_91468409 | 23.83 |
ENSMUST00000027538.9
ENSMUST00000190484.7 ENSMUST00000186068.2 |
Asb1
|
ankyrin repeat and SOCS box-containing 1 |
chrX_+_99669343 | 23.64 |
ENSMUST00000048962.4
|
Kif4
|
kinesin family member 4 |
chr3_+_90576285 | 23.39 |
ENSMUST00000069927.10
|
S100a8
|
S100 calcium binding protein A8 (calgranulin A) |
chr4_-_41314877 | 22.59 |
ENSMUST00000030145.9
|
Dcaf12
|
DDB1 and CUL4 associated factor 12 |
chr2_+_5850053 | 22.26 |
ENSMUST00000127116.7
ENSMUST00000194933.2 |
Nudt5
|
nudix (nucleoside diphosphate linked moiety X)-type motif 5 |
chr6_-_115735935 | 22.26 |
ENSMUST00000072933.13
|
Tmem40
|
transmembrane protein 40 |
chr6_-_70769135 | 21.78 |
ENSMUST00000066134.6
|
Rpia
|
ribose 5-phosphate isomerase A |
chr8_+_3715747 | 21.70 |
ENSMUST00000014118.4
|
Mcemp1
|
mast cell expressed membrane protein 1 |
chr11_-_94544748 | 21.63 |
ENSMUST00000039949.5
|
Eme1
|
essential meiotic structure-specific endonuclease 1 |
chr19_-_9876745 | 21.49 |
ENSMUST00000237725.2
|
Incenp
|
inner centromere protein |
chr2_-_167334746 | 21.46 |
ENSMUST00000109211.9
ENSMUST00000057627.16 |
Spata2
|
spermatogenesis associated 2 |
chr7_-_142215595 | 21.34 |
ENSMUST00000145896.3
|
Igf2
|
insulin-like growth factor 2 |
chr16_-_36188086 | 21.05 |
ENSMUST00000096089.3
|
Cstdc5
|
cystatin domain containing 5 |
chr17_+_37180437 | 20.78 |
ENSMUST00000060524.11
|
Trim10
|
tripartite motif-containing 10 |
chr9_-_70328816 | 20.77 |
ENSMUST00000034742.8
|
Ccnb2
|
cyclin B2 |
chr8_+_84682136 | 20.64 |
ENSMUST00000005607.9
|
Asf1b
|
anti-silencing function 1B histone chaperone |
chr19_-_6996696 | 20.48 |
ENSMUST00000236188.2
|
Fermt3
|
fermitin family member 3 |
chr6_-_8259098 | 20.45 |
ENSMUST00000012627.5
|
Rpa3
|
replication protein A3 |
chr4_-_119047202 | 20.45 |
ENSMUST00000239029.2
ENSMUST00000138395.9 ENSMUST00000156746.3 |
Ermap
|
erythroblast membrane-associated protein |
chr17_+_35460722 | 20.30 |
ENSMUST00000068056.12
ENSMUST00000174757.8 ENSMUST00000173731.8 |
Ddx39b
|
DEAD box helicase 39b |
chr17_-_34109513 | 20.25 |
ENSMUST00000173386.2
ENSMUST00000114361.9 ENSMUST00000173492.9 |
Kifc1
|
kinesin family member C1 |
chr4_-_140805613 | 20.20 |
ENSMUST00000030760.15
|
Necap2
|
NECAP endocytosis associated 2 |
chr14_-_70864448 | 20.04 |
ENSMUST00000110984.4
|
Dmtn
|
dematin actin binding protein |
chr7_-_142213219 | 20.00 |
ENSMUST00000121128.8
|
Igf2
|
insulin-like growth factor 2 |
chr4_-_46138397 | 19.91 |
ENSMUST00000144495.2
ENSMUST00000107770.2 ENSMUST00000156021.2 ENSMUST00000107772.8 |
Tstd2
|
thiosulfate sulfurtransferase (rhodanese)-like domain containing 2 |
chr10_-_78080436 | 19.62 |
ENSMUST00000000384.8
|
Trappc10
|
trafficking protein particle complex 10 |
chr1_-_171061838 | 19.62 |
ENSMUST00000193973.2
|
Fcer1g
|
Fc receptor, IgE, high affinity I, gamma polypeptide |
chr8_+_23464860 | 19.43 |
ENSMUST00000110688.9
ENSMUST00000121802.9 |
Ank1
|
ankyrin 1, erythroid |
chr6_+_86348286 | 19.33 |
ENSMUST00000089558.7
|
Snrpg
|
small nuclear ribonucleoprotein polypeptide G |
chr4_-_119177614 | 19.30 |
ENSMUST00000147077.8
ENSMUST00000056458.14 ENSMUST00000106321.9 ENSMUST00000106319.8 ENSMUST00000106317.2 ENSMUST00000106318.8 |
Ppih
|
peptidyl prolyl isomerase H |
chr3_-_14843512 | 18.56 |
ENSMUST00000094365.11
|
Car1
|
carbonic anhydrase 1 |
chr2_+_152689881 | 18.51 |
ENSMUST00000164120.8
ENSMUST00000178997.8 ENSMUST00000109816.8 |
Tpx2
|
TPX2, microtubule-associated |
chr10_-_75776437 | 18.43 |
ENSMUST00000219979.2
|
Gm867
|
predicted gene 867 |
chr17_-_29483075 | 18.30 |
ENSMUST00000024802.10
|
Ppil1
|
peptidylprolyl isomerase (cyclophilin)-like 1 |
chr17_+_46961250 | 18.16 |
ENSMUST00000043464.14
|
Cul7
|
cullin 7 |
chr2_+_164647002 | 18.09 |
ENSMUST00000052107.5
|
Zswim3
|
zinc finger SWIM-type containing 3 |
chr9_-_65487322 | 18.04 |
ENSMUST00000068944.9
|
Plekho2
|
pleckstrin homology domain containing, family O member 2 |
chr7_-_132415257 | 18.00 |
ENSMUST00000097999.9
|
Fam53b
|
family with sequence similarity 53, member B |
chr1_-_132295617 | 17.99 |
ENSMUST00000142609.8
|
Tmcc2
|
transmembrane and coiled-coil domains 2 |
chr10_+_79715448 | 17.88 |
ENSMUST00000006679.15
|
Prtn3
|
proteinase 3 |
chr5_+_33815466 | 17.75 |
ENSMUST00000074849.13
ENSMUST00000079534.11 ENSMUST00000201633.2 |
Tacc3
|
transforming, acidic coiled-coil containing protein 3 |
chr4_+_44300876 | 17.74 |
ENSMUST00000045607.12
|
Melk
|
maternal embryonic leucine zipper kinase |
chr19_-_7319157 | 17.61 |
ENSMUST00000164205.8
ENSMUST00000165286.8 ENSMUST00000168324.2 ENSMUST00000032557.15 |
Mark2
|
MAP/microtubule affinity regulating kinase 2 |
chr18_+_62086122 | 17.54 |
ENSMUST00000051720.6
ENSMUST00000235860.2 |
Sh3tc2
|
SH3 domain and tetratricopeptide repeats 2 |
chr2_+_5849828 | 17.53 |
ENSMUST00000026927.10
ENSMUST00000179748.8 |
Nudt5
|
nudix (nucleoside diphosphate linked moiety X)-type motif 5 |
chr2_-_163486998 | 17.52 |
ENSMUST00000017851.4
|
Serinc3
|
serine incorporator 3 |
chr12_-_78953703 | 17.49 |
ENSMUST00000021544.8
|
Plek2
|
pleckstrin 2 |
chr4_-_118294521 | 17.39 |
ENSMUST00000006565.13
|
Cdc20
|
cell division cycle 20 |
chr4_+_154096188 | 17.29 |
ENSMUST00000169622.8
ENSMUST00000030894.15 |
Lrrc47
|
leucine rich repeat containing 47 |
chr8_+_85628557 | 17.27 |
ENSMUST00000067060.10
ENSMUST00000239392.2 |
Klf1
|
Kruppel-like factor 1 (erythroid) |
chr17_-_24292453 | 17.26 |
ENSMUST00000017090.6
|
Kctd5
|
potassium channel tetramerisation domain containing 5 |
chr7_-_45173193 | 17.16 |
ENSMUST00000211212.2
|
Ppp1r15a
|
protein phosphatase 1, regulatory subunit 15A |
chr2_+_84670956 | 17.07 |
ENSMUST00000111625.2
|
Slc43a1
|
solute carrier family 43, member 1 |
chr1_-_85526517 | 16.99 |
ENSMUST00000093508.7
|
Sp110
|
Sp110 nuclear body protein |
chrX_-_7956682 | 16.99 |
ENSMUST00000033505.7
|
Was
|
Wiskott-Aldrich syndrome |
chr11_+_101207021 | 16.96 |
ENSMUST00000142640.8
ENSMUST00000019470.14 |
Psme3
|
proteaseome (prosome, macropain) activator subunit 3 (PA28 gamma, Ki) |
chr17_+_34824827 | 16.94 |
ENSMUST00000037489.15
|
Agpat1
|
1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha) |
chr1_-_171061902 | 16.91 |
ENSMUST00000079957.12
|
Fcer1g
|
Fc receptor, IgE, high affinity I, gamma polypeptide |
chr11_+_69805005 | 16.86 |
ENSMUST00000057884.6
|
Gps2
|
G protein pathway suppressor 2 |
chr2_-_181333597 | 16.75 |
ENSMUST00000108778.8
ENSMUST00000165416.8 |
Rgs19
|
regulator of G-protein signaling 19 |
chr5_+_121342544 | 16.72 |
ENSMUST00000031617.13
|
Rpl6
|
ribosomal protein L6 |
chr17_-_24746911 | 16.68 |
ENSMUST00000176652.8
|
Traf7
|
TNF receptor-associated factor 7 |
chr4_-_122779742 | 16.65 |
ENSMUST00000128485.2
|
Cap1
|
CAP, adenylate cyclase-associated protein 1 (yeast) |
chr8_-_86107593 | 16.61 |
ENSMUST00000122452.8
|
Mylk3
|
myosin light chain kinase 3 |
chr14_+_70337540 | 16.59 |
ENSMUST00000022680.9
|
Bin3
|
bridging integrator 3 |
chr7_-_12743720 | 16.56 |
ENSMUST00000210282.2
ENSMUST00000172240.2 ENSMUST00000051390.9 ENSMUST00000209997.2 |
Zbtb45
|
zinc finger and BTB domain containing 45 |
chr7_-_98887770 | 16.56 |
ENSMUST00000064231.8
|
Mogat2
|
monoacylglycerol O-acyltransferase 2 |
chr2_-_164198427 | 16.54 |
ENSMUST00000109367.10
|
Slpi
|
secretory leukocyte peptidase inhibitor |
chr4_-_132260799 | 16.54 |
ENSMUST00000152993.8
ENSMUST00000067496.7 |
Atpif1
|
ATPase inhibitory factor 1 |
chr4_-_119047167 | 16.53 |
ENSMUST00000030396.15
|
Ermap
|
erythroblast membrane-associated protein |
chr1_+_171216480 | 16.52 |
ENSMUST00000056449.9
|
Arhgap30
|
Rho GTPase activating protein 30 |
chr9_+_55997246 | 16.50 |
ENSMUST00000059206.8
|
Pstpip1
|
proline-serine-threonine phosphatase-interacting protein 1 |
chr14_-_70864666 | 16.46 |
ENSMUST00000022694.17
|
Dmtn
|
dematin actin binding protein |
chr7_-_126391388 | 16.40 |
ENSMUST00000206570.2
|
Ppp4c
|
protein phosphatase 4, catalytic subunit |
chr14_+_46997984 | 16.38 |
ENSMUST00000067426.6
|
Cdkn3
|
cyclin-dependent kinase inhibitor 3 |
chr16_+_48814548 | 16.34 |
ENSMUST00000117994.8
ENSMUST00000048374.6 |
Cip2a
|
cell proliferation regulating inhibitor of protein phosphatase 2A |
chr17_-_24746804 | 16.34 |
ENSMUST00000176353.8
ENSMUST00000176237.8 |
Traf7
|
TNF receptor-associated factor 7 |
chr3_-_129625023 | 16.29 |
ENSMUST00000029643.15
|
Gar1
|
GAR1 ribonucleoprotein |
chr2_+_84670543 | 15.99 |
ENSMUST00000111624.8
|
Slc43a1
|
solute carrier family 43, member 1 |
chr8_-_94763634 | 15.97 |
ENSMUST00000212981.2
ENSMUST00000034204.11 |
Nudt21
|
nudix (nucleoside diphosphate linked moiety X)-type motif 21 |
chr4_-_116485118 | 15.89 |
ENSMUST00000030456.14
|
Nasp
|
nuclear autoantigenic sperm protein (histone-binding) |
chrX_+_135039745 | 15.88 |
ENSMUST00000116527.2
|
Bex4
|
brain expressed X-linked 4 |
chr9_+_106306598 | 15.74 |
ENSMUST00000150576.8
|
Rpl29
|
ribosomal protein L29 |
chr9_+_106306736 | 15.57 |
ENSMUST00000098994.7
ENSMUST00000059802.7 ENSMUST00000213448.2 ENSMUST00000217081.2 |
Rpl29
|
ribosomal protein L29 |
chr2_-_164197987 | 15.56 |
ENSMUST00000165980.2
|
Slpi
|
secretory leukocyte peptidase inhibitor |
chr1_+_91468266 | 15.45 |
ENSMUST00000086843.11
|
Asb1
|
ankyrin repeat and SOCS box-containing 1 |
chr1_+_134110142 | 15.38 |
ENSMUST00000082060.10
ENSMUST00000153856.8 ENSMUST00000133701.8 ENSMUST00000132873.8 |
Chil1
|
chitinase-like 1 |
chr6_-_39397334 | 15.30 |
ENSMUST00000031985.13
|
Mkrn1
|
makorin, ring finger protein, 1 |
chr7_-_142223662 | 15.29 |
ENSMUST00000228850.2
|
Gm49394
|
predicted gene, 49394 |
chr5_+_33815910 | 15.23 |
ENSMUST00000114426.10
|
Tacc3
|
transforming, acidic coiled-coil containing protein 3 |
chr19_-_5776268 | 15.14 |
ENSMUST00000075606.6
ENSMUST00000236215.2 ENSMUST00000235730.2 ENSMUST00000237081.2 ENSMUST00000049295.15 |
Ehbp1l1
|
EH domain binding protein 1-like 1 |
chr8_+_85428059 | 15.11 |
ENSMUST00000238364.2
ENSMUST00000238562.2 ENSMUST00000037165.6 |
Lyl1
|
lymphoblastomic leukemia 1 |
chr4_-_45320579 | 15.05 |
ENSMUST00000030003.10
|
Exosc3
|
exosome component 3 |
chr2_-_172212426 | 15.04 |
ENSMUST00000109139.8
ENSMUST00000028997.8 ENSMUST00000109140.10 |
Aurka
|
aurora kinase A |
chr7_-_132415528 | 15.04 |
ENSMUST00000097998.9
|
Fam53b
|
family with sequence similarity 53, member B |
chr1_+_135060431 | 15.01 |
ENSMUST00000187985.7
ENSMUST00000049449.11 |
Ptpn7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr11_+_69804714 | 14.95 |
ENSMUST00000072581.9
ENSMUST00000116358.8 |
Gps2
|
G protein pathway suppressor 2 |
chr7_+_12656217 | 14.94 |
ENSMUST00000108539.8
ENSMUST00000004554.14 ENSMUST00000147435.8 ENSMUST00000137329.4 |
Rps5
|
ribosomal protein S5 |
chr19_-_4109446 | 14.94 |
ENSMUST00000189808.7
|
Gstp3
|
glutathione S-transferase pi 3 |
chr4_-_122779698 | 14.91 |
ENSMUST00000069533.12
|
Cap1
|
CAP, adenylate cyclase-associated protein 1 (yeast) |
chr5_-_148336711 | 14.87 |
ENSMUST00000048116.15
|
Slc7a1
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
chr11_-_46203047 | 14.87 |
ENSMUST00000129474.2
ENSMUST00000093166.11 ENSMUST00000165599.9 |
Cyfip2
|
cytoplasmic FMR1 interacting protein 2 |
chr1_+_174000304 | 14.87 |
ENSMUST00000027817.8
|
Spta1
|
spectrin alpha, erythrocytic 1 |
chr1_+_91468796 | 14.86 |
ENSMUST00000188081.7
ENSMUST00000188879.2 |
Asb1
|
ankyrin repeat and SOCS box-containing 1 |
chr5_-_138170644 | 14.83 |
ENSMUST00000000505.16
|
Mcm7
|
minichromosome maintenance complex component 7 |
chr19_-_10554726 | 14.64 |
ENSMUST00000025568.3
|
Tmem138
|
transmembrane protein 138 |
chr4_-_135780660 | 14.64 |
ENSMUST00000102536.11
|
Rpl11
|
ribosomal protein L11 |
chr11_-_72441054 | 14.61 |
ENSMUST00000021154.7
|
Spns3
|
spinster homolog 3 |
chr9_-_45896110 | 14.61 |
ENSMUST00000215060.2
ENSMUST00000213853.2 ENSMUST00000216334.2 |
Pafah1b2
|
platelet-activating factor acetylhydrolase, isoform 1b, subunit 2 |
chr16_-_18630365 | 14.57 |
ENSMUST00000096990.10
|
Cdc45
|
cell division cycle 45 |
chr2_-_130021229 | 14.57 |
ENSMUST00000103199.9
|
Snrpb
|
small nuclear ribonucleoprotein B |
chr4_-_63321591 | 14.55 |
ENSMUST00000035724.5
|
Akna
|
AT-hook transcription factor |
chr7_+_109118345 | 14.55 |
ENSMUST00000143107.2
|
Rpl27a
|
ribosomal protein L27A |
chr16_-_21980200 | 14.44 |
ENSMUST00000115379.2
|
Igf2bp2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr17_+_47816074 | 14.44 |
ENSMUST00000183177.8
ENSMUST00000182848.8 |
Ccnd3
|
cyclin D3 |
chr17_-_34174631 | 14.38 |
ENSMUST00000174609.9
ENSMUST00000008812.9 |
Rps18
|
ribosomal protein S18 |
chr17_+_48666919 | 14.32 |
ENSMUST00000224001.2
ENSMUST00000024792.8 ENSMUST00000225849.2 |
Treml1
|
triggering receptor expressed on myeloid cells-like 1 |
chr11_-_6470918 | 14.30 |
ENSMUST00000003459.4
|
Myo1g
|
myosin IG |
chr2_+_152689913 | 14.28 |
ENSMUST00000028969.9
|
Tpx2
|
TPX2, microtubule-associated |
chr6_-_39397212 | 14.25 |
ENSMUST00000114822.2
ENSMUST00000051671.11 |
Mkrn1
|
makorin, ring finger protein, 1 |
chr3_-_130524024 | 14.24 |
ENSMUST00000079085.11
|
Rpl34
|
ribosomal protein L34 |
chr3_-_129763638 | 14.23 |
ENSMUST00000146340.2
ENSMUST00000153506.8 |
Mcub
|
mitochondrial calcium uniporter dominant negative beta subunit |
chr19_+_32463151 | 14.23 |
ENSMUST00000025827.10
|
Minpp1
|
multiple inositol polyphosphate histidine phosphatase 1 |
chr11_-_121120052 | 14.23 |
ENSMUST00000169393.8
ENSMUST00000106115.8 ENSMUST00000038709.14 ENSMUST00000147490.6 |
Cybc1
|
cytochrome b 245 chaperone 1 |
chr19_+_18690556 | 14.18 |
ENSMUST00000062753.3
|
D030056L22Rik
|
RIKEN cDNA D030056L22 gene |
chr18_+_60907668 | 14.11 |
ENSMUST00000025511.11
|
Rps14
|
ribosomal protein S14 |
chr7_+_142014546 | 13.93 |
ENSMUST00000105968.8
ENSMUST00000018963.11 ENSMUST00000105967.8 |
Lsp1
|
lymphocyte specific 1 |
chr15_+_85743887 | 13.92 |
ENSMUST00000170629.3
|
Gtse1
|
G two S phase expressed protein 1 |
chr16_-_19801781 | 13.91 |
ENSMUST00000058839.10
|
Klhl6
|
kelch-like 6 |
chr5_+_143803540 | 13.89 |
ENSMUST00000100487.6
|
Eif2ak1
|
eukaryotic translation initiation factor 2 alpha kinase 1 |
chr19_-_46033353 | 13.89 |
ENSMUST00000026252.14
ENSMUST00000156585.9 ENSMUST00000185355.7 ENSMUST00000152946.8 |
Ldb1
|
LIM domain binding 1 |
chr18_+_60907698 | 13.86 |
ENSMUST00000118551.8
|
Rps14
|
ribosomal protein S14 |
chr15_+_78128990 | 13.86 |
ENSMUST00000096357.12
|
Ncf4
|
neutrophil cytosolic factor 4 |
chr19_+_18690589 | 13.76 |
ENSMUST00000055792.8
|
D030056L22Rik
|
RIKEN cDNA D030056L22 gene |
chr2_+_156681991 | 13.73 |
ENSMUST00000073352.10
|
Tgif2
|
TGFB-induced factor homeobox 2 |
chr17_+_47908025 | 13.73 |
ENSMUST00000183206.2
|
Ccnd3
|
cyclin D3 |
chr11_+_4936824 | 13.71 |
ENSMUST00000109897.8
ENSMUST00000009234.16 |
Ap1b1
|
adaptor protein complex AP-1, beta 1 subunit |
chr7_+_18618605 | 13.59 |
ENSMUST00000032573.8
|
Pglyrp1
|
peptidoglycan recognition protein 1 |
chr2_-_91480096 | 13.50 |
ENSMUST00000099714.10
ENSMUST00000111333.2 |
Zfp408
|
zinc finger protein 408 |
chr2_+_156681927 | 13.48 |
ENSMUST00000081335.13
|
Tgif2
|
TGFB-induced factor homeobox 2 |
chr7_+_5065142 | 13.46 |
ENSMUST00000005041.15
ENSMUST00000209099.2 |
U2af2
|
U2 small nuclear ribonucleoprotein auxiliary factor (U2AF) 2 |
chr19_-_10554417 | 13.45 |
ENSMUST00000236099.2
|
Tmem138
|
transmembrane protein 138 |
chr6_-_83010402 | 13.35 |
ENSMUST00000089651.6
|
Dok1
|
docking protein 1 |
chr2_+_118644717 | 13.32 |
ENSMUST00000028803.14
ENSMUST00000126045.8 |
Knstrn
|
kinetochore-localized astrin/SPAG5 binding |
chr4_+_124608569 | 13.30 |
ENSMUST00000030734.5
|
Sf3a3
|
splicing factor 3a, subunit 3 |
chr2_+_131333800 | 13.30 |
ENSMUST00000110179.9
ENSMUST00000110189.9 ENSMUST00000110182.9 ENSMUST00000110183.9 ENSMUST00000110186.9 ENSMUST00000110188.8 |
Smox
|
spermine oxidase |
chrX_-_132799144 | 13.20 |
ENSMUST00000087557.12
|
Tspan6
|
tetraspanin 6 |
chr11_+_116089678 | 13.18 |
ENSMUST00000021130.7
|
Ten1
|
TEN1 telomerase capping complex subunit |
chr1_+_63216281 | 13.18 |
ENSMUST00000188524.2
|
Eef1b2
|
eukaryotic translation elongation factor 1 beta 2 |
chr7_-_4755971 | 13.17 |
ENSMUST00000183971.8
ENSMUST00000182173.2 ENSMUST00000182738.8 ENSMUST00000182111.8 ENSMUST00000184143.8 ENSMUST00000182048.2 ENSMUST00000063324.14 |
Cox6b2
|
cytochrome c oxidase subunit 6B2 |
chrX_-_8011952 | 13.17 |
ENSMUST00000115615.9
ENSMUST00000115616.8 ENSMUST00000115621.9 |
Rbm3
|
RNA binding motif (RNP1, RRM) protein 3 |
chr7_-_80994933 | 13.11 |
ENSMUST00000080813.5
|
Rps17
|
ribosomal protein S17 |
chr1_-_33708876 | 13.03 |
ENSMUST00000027312.11
|
Prim2
|
DNA primase, p58 subunit |
chr4_-_46404224 | 13.00 |
ENSMUST00000107764.9
|
Hemgn
|
hemogen |
chr7_-_126303351 | 12.99 |
ENSMUST00000106364.8
|
Coro1a
|
coronin, actin binding protein 1A |
chr5_+_129578285 | 12.98 |
ENSMUST00000053737.9
|
Sfswap
|
splicing factor SWAP |
chr11_+_72889889 | 12.98 |
ENSMUST00000021141.14
|
P2rx1
|
purinergic receptor P2X, ligand-gated ion channel, 1 |
chr10_+_43455919 | 12.96 |
ENSMUST00000214476.2
|
Cd24a
|
CD24a antigen |
chr11_+_101623836 | 12.94 |
ENSMUST00000129741.2
|
Dhx8
|
DEAH (Asp-Glu-Ala-His) box polypeptide 8 |
chr6_+_129374441 | 12.94 |
ENSMUST00000112081.9
ENSMUST00000112079.3 |
Clec1b
|
C-type lectin domain family 1, member b |
chr3_-_130523954 | 12.91 |
ENSMUST00000196202.5
ENSMUST00000133802.6 ENSMUST00000062601.14 ENSMUST00000200517.2 |
Rpl34
|
ribosomal protein L34 |
chr7_-_83304698 | 12.87 |
ENSMUST00000145610.8
|
Il16
|
interleukin 16 |
chr2_-_165242307 | 12.87 |
ENSMUST00000029213.5
|
Ocstamp
|
osteoclast stimulatory transmembrane protein |
chr4_-_43578823 | 12.82 |
ENSMUST00000030189.14
|
Gba2
|
glucosidase beta 2 |
chr7_+_24596806 | 12.81 |
ENSMUST00000003469.8
|
Cd79a
|
CD79A antigen (immunoglobulin-associated alpha) |
chrX_-_149596680 | 12.80 |
ENSMUST00000112700.8
|
Maged2
|
MAGE family member D2 |
chr19_-_10554462 | 12.76 |
ENSMUST00000236185.2
|
Tmem138
|
transmembrane protein 138 |
chr17_-_48716756 | 12.75 |
ENSMUST00000160319.8
ENSMUST00000159535.2 ENSMUST00000078800.13 ENSMUST00000046719.14 ENSMUST00000162460.8 |
Nfya
|
nuclear transcription factor-Y alpha |
chr7_-_126302315 | 12.71 |
ENSMUST00000173108.8
ENSMUST00000205515.2 |
Coro1a
|
coronin, actin binding protein 1A |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
32.7 | 98.1 | GO:0002148 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
19.8 | 59.4 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
19.0 | 76.2 | GO:0070488 | neutrophil aggregation(GO:0070488) |
16.0 | 63.8 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
14.9 | 74.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
13.0 | 78.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
9.7 | 58.5 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
9.0 | 27.0 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
8.7 | 34.8 | GO:0046898 | response to cycloheximide(GO:0046898) |
8.6 | 34.5 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
8.6 | 17.2 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
7.9 | 47.3 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
7.7 | 7.7 | GO:0071226 | cellular response to molecule of fungal origin(GO:0071226) |
7.3 | 21.8 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
6.9 | 20.6 | GO:0034118 | erythrocyte aggregation(GO:0034117) regulation of erythrocyte aggregation(GO:0034118) |
6.7 | 60.1 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
6.2 | 49.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
6.1 | 67.1 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
6.0 | 47.8 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
5.9 | 59.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
5.8 | 17.4 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
5.7 | 17.1 | GO:0035702 | monocyte homeostasis(GO:0035702) |
5.7 | 5.7 | GO:0061511 | centriole elongation(GO:0061511) |
5.7 | 28.3 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
5.5 | 44.3 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
5.5 | 16.6 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
5.5 | 27.5 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
5.3 | 10.7 | GO:0048254 | snoRNA localization(GO:0048254) |
5.3 | 63.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
5.2 | 15.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
5.2 | 41.9 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
5.2 | 31.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
5.1 | 20.2 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
5.0 | 30.2 | GO:0030043 | actin filament fragmentation(GO:0030043) |
5.0 | 40.2 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
5.0 | 20.0 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
5.0 | 20.0 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
4.9 | 24.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
4.9 | 14.6 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
4.9 | 19.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
4.9 | 29.1 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
4.8 | 19.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
4.8 | 19.2 | GO:0045575 | basophil activation(GO:0045575) |
4.7 | 28.3 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
4.6 | 13.9 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
4.6 | 119.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
4.5 | 18.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
4.5 | 13.6 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
4.5 | 54.0 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
4.5 | 26.8 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
4.3 | 12.8 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
4.2 | 25.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
4.2 | 12.6 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
4.2 | 12.5 | GO:0042128 | nitrate assimilation(GO:0042128) |
4.1 | 20.5 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
4.1 | 20.4 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
4.0 | 16.1 | GO:0010286 | heat acclimation(GO:0010286) |
4.0 | 12.0 | GO:0051439 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
4.0 | 4.0 | GO:1904172 | positive regulation of bleb assembly(GO:1904172) |
3.9 | 35.5 | GO:0046208 | spermine catabolic process(GO:0046208) |
3.9 | 11.8 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
3.9 | 101.6 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
3.9 | 19.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
3.8 | 19.1 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
3.8 | 11.4 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
3.8 | 34.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
3.8 | 11.3 | GO:1904959 | regulation of cytochrome-c oxidase activity(GO:1904959) |
3.8 | 15.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
3.8 | 7.5 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
3.7 | 18.4 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
3.7 | 3.7 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
3.6 | 10.9 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
3.6 | 18.1 | GO:0009597 | detection of virus(GO:0009597) |
3.6 | 18.0 | GO:1904171 | negative regulation of bleb assembly(GO:1904171) |
3.6 | 32.4 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
3.5 | 10.6 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
3.5 | 10.6 | GO:0006740 | NADPH regeneration(GO:0006740) |
3.5 | 17.5 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
3.4 | 10.3 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
3.4 | 20.5 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
3.4 | 17.1 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
3.4 | 16.8 | GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
3.4 | 23.5 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
3.4 | 26.8 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
3.3 | 6.7 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
3.3 | 16.5 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
3.3 | 13.2 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
3.3 | 6.6 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
3.3 | 9.8 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
3.3 | 9.8 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
3.2 | 9.7 | GO:0071846 | actin filament debranching(GO:0071846) |
3.2 | 12.9 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
3.2 | 12.9 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
3.2 | 9.6 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
3.1 | 12.4 | GO:1902363 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
3.1 | 6.2 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
3.1 | 3.1 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
3.1 | 9.2 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
3.1 | 18.4 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
3.0 | 6.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
3.0 | 54.7 | GO:0043249 | erythrocyte maturation(GO:0043249) |
3.0 | 3.0 | GO:0031627 | telomeric loop formation(GO:0031627) |
3.0 | 3.0 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
3.0 | 3.0 | GO:1902299 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
3.0 | 9.0 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
3.0 | 8.9 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
3.0 | 23.8 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
2.9 | 41.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
2.9 | 20.0 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
2.8 | 8.5 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
2.8 | 8.5 | GO:0019417 | sulfur oxidation(GO:0019417) |
2.8 | 8.5 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
2.8 | 25.2 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
2.8 | 8.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
2.8 | 8.3 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
2.8 | 8.3 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
2.8 | 2.8 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
2.7 | 5.5 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
2.7 | 13.7 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
2.7 | 8.2 | GO:0045004 | DNA replication proofreading(GO:0045004) |
2.7 | 54.3 | GO:0030953 | astral microtubule organization(GO:0030953) |
2.7 | 16.3 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
2.7 | 10.8 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
2.7 | 13.5 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
2.7 | 10.7 | GO:0072355 | histone H3-T3 phosphorylation(GO:0072355) |
2.7 | 15.9 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
2.7 | 23.9 | GO:0000022 | mitotic spindle elongation(GO:0000022) |
2.6 | 26.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
2.6 | 13.1 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
2.6 | 13.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
2.6 | 10.5 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
2.6 | 10.5 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
2.6 | 5.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
2.6 | 23.5 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
2.6 | 7.8 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) pyrimidine ribonucleotide salvage(GO:0010138) pyrimidine nucleotide salvage(GO:0032262) UMP salvage(GO:0044206) CMP metabolic process(GO:0046035) |
2.6 | 10.4 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
2.6 | 12.9 | GO:0006231 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
2.6 | 10.3 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
2.5 | 15.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
2.5 | 25.3 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
2.5 | 102.8 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
2.5 | 7.5 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
2.5 | 39.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
2.5 | 14.8 | GO:0051031 | tRNA transport(GO:0051031) |
2.5 | 7.4 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
2.5 | 24.6 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
2.4 | 19.6 | GO:0032202 | telomere assembly(GO:0032202) |
2.4 | 195.2 | GO:0002181 | cytoplasmic translation(GO:0002181) |
2.4 | 36.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
2.4 | 9.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
2.4 | 4.8 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
2.4 | 21.8 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
2.4 | 26.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
2.4 | 28.9 | GO:0001955 | blood vessel maturation(GO:0001955) |
2.4 | 7.2 | GO:0070839 | divalent metal ion export(GO:0070839) |
2.4 | 21.5 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
2.4 | 11.9 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
2.4 | 14.3 | GO:0006116 | NADH oxidation(GO:0006116) |
2.4 | 7.1 | GO:0031662 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
2.4 | 7.1 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
2.4 | 4.7 | GO:0007356 | thorax and anterior abdomen determination(GO:0007356) |
2.4 | 9.4 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
2.4 | 9.4 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
2.4 | 2.4 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
2.3 | 37.6 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
2.3 | 9.3 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
2.3 | 11.6 | GO:0000733 | DNA strand renaturation(GO:0000733) |
2.3 | 9.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
2.3 | 6.8 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
2.3 | 4.5 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
2.2 | 13.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
2.2 | 2.2 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
2.2 | 6.7 | GO:1900368 | regulation of RNA interference(GO:1900368) |
2.2 | 6.7 | GO:1904923 | regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) |
2.2 | 8.9 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
2.2 | 4.4 | GO:0002352 | B cell negative selection(GO:0002352) |
2.2 | 6.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
2.2 | 6.5 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
2.2 | 8.7 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
2.2 | 6.5 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
2.2 | 10.8 | GO:0035617 | stress granule disassembly(GO:0035617) |
2.2 | 2.2 | GO:0070668 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
2.1 | 6.4 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
2.1 | 6.4 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
2.1 | 8.6 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
2.1 | 10.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
2.1 | 6.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
2.1 | 10.6 | GO:0006742 | NADP catabolic process(GO:0006742) |
2.1 | 8.4 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
2.1 | 21.1 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
2.1 | 14.7 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
2.1 | 16.8 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
2.1 | 6.3 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
2.1 | 8.3 | GO:0043096 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
2.1 | 8.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
2.1 | 4.2 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
2.1 | 97.3 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
2.0 | 6.1 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
2.0 | 18.3 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
2.0 | 28.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
2.0 | 14.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
2.0 | 6.0 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
2.0 | 22.0 | GO:0051310 | metaphase plate congression(GO:0051310) |
2.0 | 21.9 | GO:0015074 | DNA integration(GO:0015074) |
2.0 | 7.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
2.0 | 21.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
2.0 | 9.8 | GO:0030576 | Cajal body organization(GO:0030576) |
1.9 | 13.6 | GO:0007000 | nucleolus organization(GO:0007000) |
1.9 | 13.6 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.9 | 7.7 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
1.9 | 5.8 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
1.9 | 74.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
1.9 | 3.8 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
1.9 | 7.7 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
1.9 | 5.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
1.9 | 5.7 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
1.9 | 30.6 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
1.9 | 15.3 | GO:0061621 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
1.9 | 3.8 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
1.9 | 5.7 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
1.9 | 20.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.9 | 39.4 | GO:1904874 | positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
1.9 | 13.1 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
1.9 | 5.6 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
1.9 | 9.3 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
1.8 | 1.8 | GO:1903632 | positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
1.8 | 9.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
1.8 | 67.8 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
1.8 | 9.1 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
1.8 | 7.3 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
1.8 | 16.2 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
1.8 | 7.2 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.8 | 12.5 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
1.8 | 10.7 | GO:0070943 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
1.7 | 7.0 | GO:0048478 | replication fork protection(GO:0048478) |
1.7 | 5.2 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
1.7 | 8.6 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.7 | 22.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.7 | 5.2 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
1.7 | 5.2 | GO:0015825 | L-serine transport(GO:0015825) |
1.7 | 6.8 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
1.7 | 1.7 | GO:2001107 | negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
1.7 | 42.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.7 | 21.9 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
1.7 | 10.1 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
1.7 | 3.4 | GO:0000019 | regulation of mitotic recombination(GO:0000019) negative regulation of mitotic recombination(GO:0045950) |
1.7 | 13.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.7 | 15.1 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.7 | 6.7 | GO:0045659 | negative regulation of neutrophil differentiation(GO:0045659) |
1.7 | 26.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.7 | 6.7 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
1.7 | 11.7 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) |
1.7 | 5.0 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.7 | 5.0 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
1.7 | 21.5 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
1.7 | 54.5 | GO:0030539 | male genitalia development(GO:0030539) |
1.6 | 3.3 | GO:0014064 | positive regulation of serotonin secretion(GO:0014064) |
1.6 | 9.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.6 | 3.3 | GO:2000373 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
1.6 | 14.7 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
1.6 | 3.3 | GO:0072708 | response to sorbitol(GO:0072708) |
1.6 | 26.1 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
1.6 | 9.8 | GO:0007144 | female meiosis I(GO:0007144) |
1.6 | 12.9 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
1.6 | 19.4 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
1.6 | 4.8 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
1.6 | 4.8 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
1.6 | 25.8 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
1.6 | 4.8 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
1.6 | 43.5 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
1.6 | 63.9 | GO:1903146 | regulation of mitophagy(GO:1903146) |
1.6 | 25.5 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
1.6 | 12.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
1.6 | 6.3 | GO:0048296 | regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
1.6 | 22.1 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
1.6 | 14.2 | GO:0032532 | regulation of microvillus length(GO:0032532) |
1.6 | 6.3 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
1.6 | 4.7 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
1.6 | 4.7 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
1.6 | 4.7 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
1.6 | 7.8 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
1.5 | 3.1 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
1.5 | 10.7 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.5 | 4.5 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
1.5 | 6.0 | GO:0033575 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
1.5 | 12.0 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
1.5 | 46.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
1.5 | 7.5 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
1.5 | 1.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.5 | 3.0 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
1.5 | 5.9 | GO:0035844 | cloaca development(GO:0035844) |
1.5 | 16.3 | GO:0002467 | germinal center formation(GO:0002467) |
1.5 | 1.5 | GO:0003294 | atrial ventricular junction remodeling(GO:0003294) regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
1.5 | 14.7 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
1.5 | 116.3 | GO:0070527 | platelet aggregation(GO:0070527) |
1.4 | 15.8 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
1.4 | 5.7 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
1.4 | 2.9 | GO:1905216 | positive regulation of RNA binding(GO:1905216) |
1.4 | 8.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
1.4 | 4.3 | GO:1905171 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
1.4 | 17.1 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
1.4 | 2.8 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
1.4 | 4.3 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
1.4 | 11.3 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
1.4 | 4.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
1.4 | 1.4 | GO:0034769 | basement membrane disassembly(GO:0034769) |
1.4 | 7.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
1.4 | 5.6 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.4 | 12.7 | GO:0006265 | DNA topological change(GO:0006265) |
1.4 | 9.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.4 | 7.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
1.4 | 2.8 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
1.4 | 8.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
1.4 | 15.3 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
1.4 | 1.4 | GO:0046619 | optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
1.4 | 13.8 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
1.4 | 5.5 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
1.4 | 11.0 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
1.4 | 11.0 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
1.4 | 4.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
1.4 | 1.4 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
1.4 | 9.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.3 | 5.4 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
1.3 | 9.4 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
1.3 | 4.0 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
1.3 | 4.0 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.3 | 2.7 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
1.3 | 4.0 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
1.3 | 4.0 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) phosphatidylserine exposure on blood platelet(GO:0097045) |
1.3 | 7.9 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
1.3 | 18.4 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
1.3 | 14.4 | GO:0051014 | actin filament severing(GO:0051014) |
1.3 | 1.3 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
1.3 | 7.8 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
1.3 | 24.7 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
1.3 | 5.2 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
1.3 | 9.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
1.3 | 2.6 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
1.3 | 6.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.3 | 1.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
1.3 | 2.6 | GO:2000232 | regulation of rRNA processing(GO:2000232) |
1.3 | 15.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
1.3 | 50.0 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
1.3 | 5.1 | GO:2001150 | dipeptide transmembrane transport(GO:0035442) regulation of oligopeptide transport(GO:0090088) regulation of dipeptide transport(GO:0090089) positive regulation of oligopeptide transport(GO:2000878) positive regulation of dipeptide transport(GO:2000880) regulation of dipeptide transmembrane transport(GO:2001148) positive regulation of dipeptide transmembrane transport(GO:2001150) |
1.3 | 16.5 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.3 | 5.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
1.3 | 12.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.3 | 7.6 | GO:0044351 | macropinocytosis(GO:0044351) |
1.3 | 3.8 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
1.3 | 12.6 | GO:0021995 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
1.3 | 3.8 | GO:0002880 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
1.2 | 10.0 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
1.2 | 6.2 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
1.2 | 7.4 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
1.2 | 3.7 | GO:0035638 | patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
1.2 | 26.0 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
1.2 | 48.1 | GO:0006284 | base-excision repair(GO:0006284) |
1.2 | 3.7 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
1.2 | 4.9 | GO:0015904 | tetracycline transport(GO:0015904) |
1.2 | 7.4 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
1.2 | 9.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.2 | 1.2 | GO:0060926 | cardiac pacemaker cell differentiation(GO:0060920) cardiac pacemaker cell development(GO:0060926) |
1.2 | 58.8 | GO:0015804 | neutral amino acid transport(GO:0015804) |
1.2 | 1.2 | GO:0090672 | RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) regulation of telomerase RNA localization to Cajal body(GO:1904872) |
1.2 | 4.8 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
1.2 | 1.2 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.2 | 3.6 | GO:0071727 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
1.2 | 4.8 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
1.2 | 13.0 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
1.2 | 13.0 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
1.2 | 5.9 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
1.2 | 35.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.2 | 26.0 | GO:0016180 | snRNA processing(GO:0016180) |
1.2 | 8.3 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
1.2 | 9.4 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
1.2 | 7.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.2 | 3.5 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
1.2 | 4.7 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
1.2 | 8.1 | GO:0019661 | glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
1.2 | 32.5 | GO:0019731 | antibacterial humoral response(GO:0019731) |
1.2 | 16.2 | GO:0036344 | platelet morphogenesis(GO:0036344) |
1.2 | 4.6 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
1.2 | 2.3 | GO:1990869 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
1.1 | 1.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.1 | 17.2 | GO:0007099 | centriole replication(GO:0007099) |
1.1 | 4.6 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
1.1 | 1.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
1.1 | 6.8 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
1.1 | 9.0 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
1.1 | 5.6 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
1.1 | 27.9 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
1.1 | 4.5 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
1.1 | 5.6 | GO:0031509 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
1.1 | 23.4 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
1.1 | 20.0 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
1.1 | 4.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
1.1 | 8.9 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.1 | 15.4 | GO:0002739 | cytokine secretion involved in immune response(GO:0002374) regulation of cytokine secretion involved in immune response(GO:0002739) positive regulation of cytokine secretion involved in immune response(GO:0002741) |
1.1 | 6.6 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
1.1 | 9.8 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
1.1 | 19.6 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
1.1 | 3.3 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
1.1 | 5.3 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.1 | 10.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
1.1 | 6.4 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
1.0 | 6.3 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
1.0 | 8.4 | GO:0031297 | replication fork processing(GO:0031297) |
1.0 | 4.2 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
1.0 | 44.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
1.0 | 22.8 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
1.0 | 7.2 | GO:0051697 | protein delipidation(GO:0051697) |
1.0 | 3.1 | GO:0036245 | cellular response to menadione(GO:0036245) |
1.0 | 7.2 | GO:0080009 | mRNA methylation(GO:0080009) |
1.0 | 16.4 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
1.0 | 4.1 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
1.0 | 5.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
1.0 | 2.0 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
1.0 | 5.0 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
1.0 | 3.0 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
1.0 | 2.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
1.0 | 2.0 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
1.0 | 10.9 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
1.0 | 11.8 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
1.0 | 14.8 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
1.0 | 23.4 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
1.0 | 11.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
1.0 | 3.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.0 | 16.3 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
1.0 | 3.8 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
1.0 | 4.8 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.0 | 8.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
1.0 | 6.7 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) positive regulation of neutrophil apoptotic process(GO:0033031) |
1.0 | 4.8 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.9 | 3.8 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.9 | 11.3 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.9 | 17.9 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.9 | 0.9 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.9 | 1.9 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.9 | 5.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.9 | 2.8 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.9 | 3.8 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.9 | 1.9 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.9 | 50.5 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.9 | 0.9 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.9 | 26.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.9 | 2.8 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.9 | 2.8 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.9 | 2.8 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.9 | 3.7 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.9 | 9.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.9 | 2.8 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.9 | 37.8 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.9 | 5.5 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.9 | 0.9 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.9 | 13.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.9 | 16.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.9 | 6.3 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.9 | 4.5 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.9 | 0.9 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.9 | 8.0 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.9 | 3.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.9 | 0.9 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.9 | 3.5 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.9 | 34.0 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.9 | 4.4 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.9 | 2.6 | GO:0021764 | amygdala development(GO:0021764) |
0.9 | 4.3 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.9 | 2.6 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.9 | 3.4 | GO:0071105 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
0.9 | 3.4 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.9 | 1.7 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.9 | 5.1 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.9 | 6.8 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.9 | 11.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.8 | 1.7 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.8 | 5.1 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.8 | 15.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.8 | 6.7 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.8 | 1.7 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.8 | 3.3 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.8 | 1.7 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.8 | 9.2 | GO:0070269 | pyroptosis(GO:0070269) |
0.8 | 2.5 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
0.8 | 8.3 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.8 | 5.8 | GO:0016266 | O-glycan processing(GO:0016266) |
0.8 | 2.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.8 | 2.5 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.8 | 13.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.8 | 7.4 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.8 | 2.5 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.8 | 3.3 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
0.8 | 1.6 | GO:1904970 | brush border assembly(GO:1904970) |
0.8 | 3.3 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.8 | 2.4 | GO:0032218 | riboflavin transport(GO:0032218) |
0.8 | 7.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.8 | 7.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.8 | 2.4 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.8 | 4.0 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.8 | 9.6 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.8 | 4.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.8 | 12.0 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.8 | 7.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.8 | 28.7 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.8 | 7.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.8 | 5.5 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.8 | 7.9 | GO:0060056 | mammary gland involution(GO:0060056) |
0.8 | 6.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.8 | 15.6 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.8 | 7.0 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.8 | 17.0 | GO:0006301 | postreplication repair(GO:0006301) |
0.8 | 27.8 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.8 | 6.9 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.8 | 7.6 | GO:0033280 | response to vitamin D(GO:0033280) |
0.8 | 10.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.8 | 24.1 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.7 | 6.0 | GO:0035878 | nail development(GO:0035878) |
0.7 | 5.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.7 | 2.2 | GO:1990918 | meiotic DNA double-strand break processing involved in reciprocal meiotic recombination(GO:0010705) double-strand break repair involved in meiotic recombination(GO:1990918) |
0.7 | 3.7 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.7 | 2.2 | GO:0033505 | floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
0.7 | 1.5 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.7 | 16.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.7 | 0.7 | GO:1901563 | response to camptothecin(GO:1901563) |
0.7 | 4.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.7 | 21.2 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.7 | 3.7 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.7 | 56.8 | GO:0006413 | translational initiation(GO:0006413) |
0.7 | 2.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.7 | 2.9 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.7 | 47.8 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.7 | 2.2 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.7 | 12.9 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.7 | 3.6 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
0.7 | 2.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.7 | 18.6 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.7 | 4.3 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.7 | 11.4 | GO:0015809 | arginine transport(GO:0015809) |
0.7 | 32.8 | GO:0051028 | mRNA transport(GO:0051028) |
0.7 | 10.7 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.7 | 76.3 | GO:0000910 | cytokinesis(GO:0000910) |
0.7 | 17.8 | GO:0035196 | production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
0.7 | 1.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.7 | 3.6 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
0.7 | 0.7 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
0.7 | 2.1 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) |
0.7 | 31.8 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.7 | 2.1 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.7 | 2.8 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.7 | 1.4 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.7 | 1.4 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.7 | 7.7 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.7 | 12.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.7 | 11.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.7 | 4.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.7 | 2.7 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.7 | 10.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.7 | 0.7 | GO:1904429 | regulation of t-circle formation(GO:1904429) |
0.7 | 1.4 | GO:0042119 | neutrophil activation(GO:0042119) |
0.7 | 6.1 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.7 | 7.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.7 | 128.8 | GO:0000398 | RNA splicing, via transesterification reactions(GO:0000375) RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.7 | 4.7 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.7 | 2.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.7 | 56.5 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.7 | 6.7 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.7 | 6.0 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.7 | 12.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.7 | 4.0 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
0.7 | 4.6 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.7 | 29.8 | GO:0051225 | spindle assembly(GO:0051225) |
0.7 | 3.3 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.7 | 5.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.7 | 2.0 | GO:2000156 | regulation of retrograde vesicle-mediated transport, Golgi to ER(GO:2000156) |
0.7 | 13.1 | GO:0045730 | respiratory burst(GO:0045730) |
0.7 | 6.5 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.7 | 9.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.7 | 3.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.6 | 3.9 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.6 | 1.9 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.6 | 0.6 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.6 | 1.3 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.6 | 3.2 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.6 | 2.6 | GO:0048069 | eye pigmentation(GO:0048069) |
0.6 | 45.4 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.6 | 1.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.6 | 3.8 | GO:0000012 | single strand break repair(GO:0000012) |
0.6 | 2.5 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.6 | 2.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.6 | 1.9 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
0.6 | 1.2 | GO:0009644 | response to high light intensity(GO:0009644) |
0.6 | 3.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.6 | 6.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.6 | 3.7 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.6 | 29.0 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.6 | 1.2 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
0.6 | 2.4 | GO:0033366 | protein localization to secretory granule(GO:0033366) protein localization to mast cell secretory granule(GO:0033367) protease localization to mast cell secretory granule(GO:0033368) maintenance of protein location in mast cell secretory granule(GO:0033370) T cell secretory granule organization(GO:0033371) maintenance of protease location in mast cell secretory granule(GO:0033373) protein localization to T cell secretory granule(GO:0033374) protease localization to T cell secretory granule(GO:0033375) maintenance of protein location in T cell secretory granule(GO:0033377) maintenance of protease location in T cell secretory granule(GO:0033379) granzyme B localization to T cell secretory granule(GO:0033380) maintenance of granzyme B location in T cell secretory granule(GO:0033382) |
0.6 | 1.2 | GO:0060437 | lung growth(GO:0060437) |
0.6 | 19.5 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.6 | 0.6 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.6 | 9.7 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.6 | 2.4 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.6 | 1.8 | GO:0015867 | ATP transport(GO:0015867) |
0.6 | 3.6 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.6 | 5.4 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.6 | 3.6 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.6 | 15.1 | GO:0032109 | positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.6 | 1.2 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
0.6 | 1.2 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.6 | 26.6 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.6 | 1.7 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.6 | 2.3 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.6 | 4.6 | GO:0033028 | myeloid cell apoptotic process(GO:0033028) |
0.6 | 0.6 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.6 | 2.9 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.6 | 2.8 | GO:0044838 | cell quiescence(GO:0044838) |
0.6 | 2.8 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.6 | 1.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.6 | 11.3 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.6 | 0.6 | GO:0060100 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.6 | 1.7 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.6 | 4.5 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.6 | 2.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.6 | 2.8 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.6 | 3.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.5 | 21.4 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.5 | 4.4 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.5 | 1.1 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
0.5 | 9.8 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.5 | 2.7 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.5 | 0.5 | GO:0061009 | common bile duct development(GO:0061009) |
0.5 | 1.1 | GO:0034088 | maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.5 | 2.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.5 | 9.0 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.5 | 2.1 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.5 | 0.5 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.5 | 1.0 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.5 | 4.2 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.5 | 3.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.5 | 3.6 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.5 | 8.7 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.5 | 2.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.5 | 1.5 | GO:0090673 | endothelial cell-matrix adhesion(GO:0090673) |
0.5 | 5.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.5 | 2.0 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.5 | 1.5 | GO:2000845 | positive regulation of testosterone secretion(GO:2000845) |
0.5 | 4.0 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.5 | 14.3 | GO:0030168 | platelet activation(GO:0030168) |
0.5 | 5.9 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.5 | 1.0 | GO:2000473 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
0.5 | 5.9 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.5 | 1.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.5 | 7.2 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.5 | 2.9 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.5 | 4.3 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.5 | 3.8 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.5 | 4.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.5 | 0.5 | GO:1990743 | protein sialylation(GO:1990743) |
0.5 | 1.9 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
0.5 | 1.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.5 | 3.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.5 | 2.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.5 | 0.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.5 | 2.8 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.5 | 2.8 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.5 | 2.3 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.5 | 2.7 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.5 | 5.0 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.5 | 13.7 | GO:0007051 | spindle organization(GO:0007051) |
0.5 | 0.5 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.5 | 1.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.4 | 7.2 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.4 | 4.9 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.4 | 1.8 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.4 | 1.8 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
0.4 | 1.8 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.4 | 2.2 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.4 | 3.5 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.4 | 9.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.4 | 4.8 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.4 | 1.7 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.4 | 2.6 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.4 | 1.7 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.4 | 2.6 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.4 | 1.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.4 | 1.7 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.4 | 1.3 | GO:2000299 | negative regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000299) |
0.4 | 10.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.4 | 0.8 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.4 | 21.8 | GO:0045576 | mast cell activation(GO:0045576) |
0.4 | 1.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.4 | 9.6 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.4 | 2.1 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.4 | 1.7 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.4 | 0.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.4 | 3.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.4 | 2.0 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.4 | 6.9 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.4 | 21.6 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.4 | 1.6 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.4 | 2.4 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.4 | 1.6 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
0.4 | 3.6 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.4 | 4.0 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.4 | 6.3 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.4 | 2.0 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.4 | 0.4 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.4 | 1.2 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.4 | 2.3 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.4 | 0.4 | GO:0031296 | B cell costimulation(GO:0031296) |
0.4 | 3.4 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.4 | 3.0 | GO:0070986 | left/right axis specification(GO:0070986) |
0.4 | 13.9 | GO:0006414 | translational elongation(GO:0006414) |
0.4 | 1.5 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.4 | 1.5 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.4 | 0.4 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.4 | 4.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.4 | 51.3 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.4 | 37.9 | GO:0008380 | RNA splicing(GO:0008380) |
0.4 | 4.0 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.4 | 1.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.4 | 1.5 | GO:0034214 | protein hexamerization(GO:0034214) |
0.4 | 3.3 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.4 | 7.7 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.4 | 5.8 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.4 | 1.4 | GO:0003017 | lymph circulation(GO:0003017) |
0.4 | 1.8 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.4 | 2.2 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.4 | 1.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.4 | 0.7 | GO:2000674 | regulation of type B pancreatic cell apoptotic process(GO:2000674) |
0.4 | 1.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.4 | 1.8 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.4 | 4.6 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.3 | 4.2 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.3 | 0.7 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.3 | 1.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.3 | 10.5 | GO:0016925 | protein sumoylation(GO:0016925) |
0.3 | 1.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.3 | 1.7 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.3 | 5.4 | GO:0048821 | erythrocyte development(GO:0048821) |
0.3 | 7.0 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.3 | 7.7 | GO:0030183 | B cell differentiation(GO:0030183) |
0.3 | 2.7 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.3 | 6.0 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.3 | 5.0 | GO:0030033 | microvillus assembly(GO:0030033) |
0.3 | 4.3 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.3 | 10.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.3 | 6.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 4.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 1.0 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.3 | 2.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.3 | 3.5 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.3 | 1.3 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.3 | 1.3 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.3 | 0.9 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.3 | 1.6 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.3 | 2.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.3 | 7.1 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.3 | 2.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.3 | 2.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 0.9 | GO:0033189 | response to vitamin A(GO:0033189) |
0.3 | 5.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.3 | 0.9 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
0.3 | 2.4 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.3 | 1.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.3 | 1.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.3 | 1.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 9.9 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.3 | 2.3 | GO:1990182 | exosomal secretion(GO:1990182) |
0.3 | 0.6 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) |
0.3 | 0.6 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.3 | 0.6 | GO:0001510 | RNA methylation(GO:0001510) |
0.3 | 0.6 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.3 | 6.6 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.3 | 1.6 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.3 | 2.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.3 | 0.5 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.3 | 5.4 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.3 | 0.5 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.3 | 9.7 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 1.9 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.3 | 6.7 | GO:0042100 | B cell proliferation(GO:0042100) |
0.3 | 8.3 | GO:0046677 | response to antibiotic(GO:0046677) |
0.3 | 0.8 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.3 | 9.2 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.3 | 2.1 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.3 | 3.9 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.3 | 0.3 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.3 | 0.8 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 1.8 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.3 | 0.8 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.2 | 3.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 0.5 | GO:1903551 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.2 | 2.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 1.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 7.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.2 | 3.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.7 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.2 | 1.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.2 | 16.4 | GO:0031109 | microtubule polymerization or depolymerization(GO:0031109) |
0.2 | 1.0 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.2 | 5.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 1.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.2 | 2.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 2.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.7 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
0.2 | 0.9 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.2 | 1.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.2 | 0.7 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.2 | 2.8 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.2 | 0.2 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.2 | 0.7 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.2 | 0.7 | GO:0030887 | positive regulation of myeloid dendritic cell activation(GO:0030887) |
0.2 | 0.7 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.2 | 3.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 0.2 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.2 | 3.2 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.2 | 3.6 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.5 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 0.2 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 2.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.9 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.2 | 1.3 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.2 | 2.0 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.2 | 1.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.2 | 2.2 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.2 | 8.8 | GO:0006400 | tRNA modification(GO:0006400) |
0.2 | 0.7 | GO:0003097 | renal water transport(GO:0003097) |
0.2 | 4.8 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.2 | 1.9 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.2 | 0.2 | GO:0045359 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.2 | 2.6 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.2 | 0.4 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.2 | 4.0 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.2 | 5.1 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.2 | 2.3 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.2 | 1.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.2 | 0.4 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.2 | 0.6 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.2 | 1.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 2.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 1.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 1.4 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 1.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.4 | GO:0060003 | copper ion export(GO:0060003) |
0.2 | 0.4 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 12.0 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.2 | 0.2 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.2 | 0.6 | GO:0016240 | autophagosome docking(GO:0016240) |
0.2 | 0.2 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.2 | 1.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 4.1 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.2 | 0.4 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.2 | 3.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.2 | 5.0 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 0.6 | GO:1903596 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) regulation of gap junction assembly(GO:1903596) positive regulation of gap junction assembly(GO:1903598) |
0.2 | 25.4 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.2 | 1.7 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.2 | 2.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 1.3 | GO:0097320 | membrane tubulation(GO:0097320) |
0.2 | 0.6 | GO:0009301 | snRNA transcription(GO:0009301) |
0.2 | 1.3 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.2 | 0.5 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 0.9 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 0.4 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.2 | 0.2 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.2 | 1.4 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 1.2 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 4.8 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.2 | 0.2 | GO:1902159 | regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) |
0.2 | 1.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 2.6 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.2 | 6.1 | GO:0031424 | keratinization(GO:0031424) |
0.2 | 1.7 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.2 | 2.9 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.2 | 2.7 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 0.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 0.7 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 1.8 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 0.5 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 1.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.2 | 0.5 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
0.2 | 0.6 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.2 | 1.4 | GO:0098904 | T-tubule organization(GO:0033292) protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of AV node cell action potential(GO:0098904) regulation of SA node cell action potential(GO:0098907) |
0.2 | 0.5 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.2 | 0.3 | GO:0031179 | peptide modification(GO:0031179) |
0.2 | 0.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.2 | 2.0 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.2 | 2.7 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.2 | 0.6 | GO:1901250 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.2 | 0.6 | GO:2000983 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
0.2 | 0.6 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.2 | 0.5 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 4.9 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.6 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.1 | 0.7 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.4 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
0.1 | 0.6 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.1 | 0.4 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.1 | 2.6 | GO:0061515 | myeloid cell development(GO:0061515) |
0.1 | 0.4 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
0.1 | 0.3 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 1.4 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.1 | 2.7 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 1.0 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.1 | 0.4 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 0.7 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.1 | 1.9 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 1.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 5.1 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 1.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 7.9 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
0.1 | 1.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 1.8 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 0.4 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.5 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.7 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
0.1 | 0.4 | GO:0045628 | regulation of T-helper 2 cell differentiation(GO:0045628) |
0.1 | 1.0 | GO:0070836 | caveola assembly(GO:0070836) |
0.1 | 6.8 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.1 | 4.9 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.4 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 1.4 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.3 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.6 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 3.3 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.1 | 0.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 0.8 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.3 | GO:0090313 | regulation of protein targeting to membrane(GO:0090313) |
0.1 | 0.3 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 | 0.3 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 3.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 3.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 1.0 | GO:0030878 | thyroid gland development(GO:0030878) |
0.1 | 0.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.5 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 0.3 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.1 | 0.3 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
0.1 | 0.7 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 1.7 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.1 | 0.9 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.1 | 0.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 2.0 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
0.1 | 0.9 | GO:0055022 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.1 | 0.3 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.1 | 1.0 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 1.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 1.0 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.1 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.1 | 0.8 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 1.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.2 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.1 | 0.5 | GO:0050757 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.1 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.6 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.1 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.2 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.1 | 0.3 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.1 | 0.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 2.0 | GO:1902749 | regulation of cell cycle G2/M phase transition(GO:1902749) |
0.1 | 1.2 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.8 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.1 | 0.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.3 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.7 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.5 | GO:0007431 | salivary gland development(GO:0007431) |
0.1 | 0.5 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.7 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.1 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 0.4 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 7.7 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.1 | 3.4 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 0.1 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 1.9 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.1 | 0.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.1 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.1 | 0.2 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.1 | 0.1 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.1 | 0.4 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.1 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
0.0 | 1.8 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.0 | 0.5 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.1 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
0.0 | 0.1 | GO:0045212 | neurotransmitter receptor biosynthetic process(GO:0045212) |
0.0 | 0.1 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.0 | 0.6 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.3 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 1.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.2 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.0 | 0.2 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.0 | 0.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.2 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.0 | 0.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.7 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 0.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.0 | 0.1 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.0 | 0.2 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.0 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.3 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.0 | 0.3 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.1 | GO:0046532 | eye photoreceptor cell fate commitment(GO:0042706) regulation of photoreceptor cell differentiation(GO:0046532) negative regulation of photoreceptor cell differentiation(GO:0046533) photoreceptor cell fate commitment(GO:0046552) camera-type eye photoreceptor cell fate commitment(GO:0060220) regulation of amacrine cell differentiation(GO:1902869) |
0.0 | 0.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.0 | 0.0 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.0 | 0.0 | GO:1902683 | regulation of protein localization to synapse(GO:1902473) regulation of receptor localization to synapse(GO:1902683) |
0.0 | 0.0 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.0 | 0.0 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.2 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.0 | 0.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.0 | 0.2 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.1 | GO:0072520 | seminiferous tubule development(GO:0072520) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
19.7 | 59.0 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
12.2 | 36.5 | GO:0032997 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
10.3 | 51.7 | GO:0000799 | nuclear condensin complex(GO:0000799) |
9.5 | 66.8 | GO:0097443 | sorting endosome(GO:0097443) |
7.9 | 7.9 | GO:0031209 | SCAR complex(GO:0031209) |
6.9 | 20.6 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
6.8 | 47.3 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
6.6 | 19.8 | GO:1990031 | pinceau fiber(GO:1990031) |
6.4 | 19.3 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
6.3 | 106.4 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
6.2 | 30.8 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
6.0 | 60.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
5.9 | 70.4 | GO:0005687 | U4 snRNP(GO:0005687) |
5.6 | 50.7 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
5.4 | 16.3 | GO:0034455 | t-UTP complex(GO:0034455) |
5.3 | 69.0 | GO:0042555 | MCM complex(GO:0042555) |
5.1 | 30.8 | GO:0032133 | chromosome passenger complex(GO:0032133) |
5.1 | 25.7 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
5.0 | 60.5 | GO:0000801 | central element(GO:0000801) |
5.0 | 19.9 | GO:0035101 | FACT complex(GO:0035101) |
4.9 | 63.9 | GO:0097450 | astrocyte end-foot(GO:0097450) |
4.7 | 14.0 | GO:1990879 | CST complex(GO:1990879) |
4.5 | 22.7 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
4.5 | 4.5 | GO:1990423 | RZZ complex(GO:1990423) |
4.5 | 62.6 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
4.4 | 31.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
4.4 | 17.6 | GO:0071920 | cleavage body(GO:0071920) |
4.3 | 340.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
4.3 | 266.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
4.1 | 12.3 | GO:0034066 | RIC1-RGP1 guanyl-nucleotide exchange factor complex(GO:0034066) |
4.1 | 36.6 | GO:0097427 | microtubule bundle(GO:0097427) |
3.9 | 23.5 | GO:0008537 | proteasome activator complex(GO:0008537) |
3.9 | 31.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
3.9 | 50.3 | GO:0005818 | aster(GO:0005818) |
3.9 | 27.0 | GO:1990246 | uniplex complex(GO:1990246) |
3.7 | 25.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
3.6 | 3.6 | GO:0035061 | interchromatin granule(GO:0035061) |
3.6 | 10.8 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
3.5 | 3.5 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
3.5 | 38.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
3.5 | 24.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
3.5 | 31.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
3.4 | 44.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
3.4 | 10.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
3.4 | 57.6 | GO:0000974 | Prp19 complex(GO:0000974) |
3.3 | 46.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
3.3 | 13.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
3.3 | 10.0 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
3.3 | 29.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
3.2 | 13.0 | GO:0036284 | tubulobulbar complex(GO:0036284) |
3.2 | 77.0 | GO:0033202 | DNA helicase complex(GO:0033202) |
3.2 | 19.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
3.1 | 25.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
3.1 | 21.8 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
3.1 | 12.4 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
3.1 | 9.3 | GO:0005682 | U5 snRNP(GO:0005682) |
3.1 | 12.4 | GO:0030312 | external encapsulating structure(GO:0030312) |
3.1 | 30.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
3.0 | 18.2 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
3.0 | 20.8 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
2.9 | 41.1 | GO:0005686 | U2 snRNP(GO:0005686) |
2.9 | 8.8 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
2.9 | 43.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
2.9 | 26.0 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
2.9 | 20.1 | GO:0000796 | condensin complex(GO:0000796) |
2.9 | 20.0 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
2.9 | 14.3 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
2.7 | 38.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
2.7 | 60.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
2.7 | 34.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
2.7 | 8.0 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
2.7 | 32.0 | GO:0008278 | cohesin complex(GO:0008278) |
2.6 | 13.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
2.6 | 7.9 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
2.6 | 15.7 | GO:0042583 | chromaffin granule(GO:0042583) |
2.6 | 13.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
2.6 | 7.8 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
2.6 | 18.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
2.5 | 10.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
2.5 | 17.8 | GO:0036396 | MIS complex(GO:0036396) |
2.4 | 7.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
2.4 | 24.3 | GO:0042382 | paraspeckles(GO:0042382) |
2.4 | 14.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
2.4 | 14.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
2.3 | 18.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
2.2 | 15.7 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
2.2 | 35.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
2.2 | 13.3 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
2.2 | 4.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
2.2 | 32.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
2.2 | 146.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
2.2 | 8.7 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
2.1 | 6.4 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
2.1 | 19.1 | GO:0070652 | HAUS complex(GO:0070652) |
2.1 | 12.8 | GO:0034709 | methylosome(GO:0034709) |
2.1 | 69.8 | GO:0001891 | phagocytic cup(GO:0001891) |
2.1 | 29.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
2.0 | 152.9 | GO:0005871 | kinesin complex(GO:0005871) |
2.0 | 4.1 | GO:0097255 | R2TP complex(GO:0097255) |
2.0 | 16.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
2.0 | 8.0 | GO:0030870 | Mre11 complex(GO:0030870) |
2.0 | 42.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
2.0 | 8.0 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
2.0 | 25.7 | GO:0005688 | U6 snRNP(GO:0005688) |
2.0 | 53.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
2.0 | 5.9 | GO:0005607 | laminin-2 complex(GO:0005607) |
1.9 | 11.7 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.9 | 5.8 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
1.9 | 25.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
1.9 | 55.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.9 | 24.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
1.9 | 18.6 | GO:0000243 | commitment complex(GO:0000243) |
1.9 | 1.9 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
1.8 | 33.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
1.8 | 9.0 | GO:0071953 | elastic fiber(GO:0071953) |
1.8 | 8.9 | GO:0000125 | PCAF complex(GO:0000125) |
1.8 | 10.6 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.8 | 5.3 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
1.8 | 68.3 | GO:0002102 | podosome(GO:0002102) |
1.8 | 8.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.7 | 10.5 | GO:0031523 | Myb complex(GO:0031523) |
1.7 | 19.1 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
1.7 | 20.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
1.6 | 166.5 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
1.6 | 1.6 | GO:0019034 | viral replication complex(GO:0019034) |
1.6 | 8.1 | GO:0045160 | myosin I complex(GO:0045160) |
1.6 | 8.0 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.6 | 3.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
1.6 | 4.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.6 | 15.5 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
1.5 | 30.8 | GO:0032040 | small-subunit processome(GO:0032040) |
1.5 | 15.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.5 | 52.0 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
1.5 | 19.8 | GO:0030684 | preribosome(GO:0030684) |
1.5 | 7.5 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
1.5 | 4.4 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
1.5 | 4.4 | GO:0036501 | UFD1-NPL4 complex(GO:0036501) |
1.4 | 4.3 | GO:0034657 | GID complex(GO:0034657) |
1.4 | 70.2 | GO:0005657 | replication fork(GO:0005657) |
1.4 | 4.3 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
1.4 | 7.1 | GO:1990745 | EARP complex(GO:1990745) |
1.4 | 39.6 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
1.4 | 14.1 | GO:0070938 | contractile ring(GO:0070938) |
1.4 | 13.7 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
1.4 | 1.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.3 | 4.0 | GO:0031904 | endosome lumen(GO:0031904) |
1.3 | 13.2 | GO:0061574 | ASAP complex(GO:0061574) |
1.3 | 3.9 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
1.3 | 7.9 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
1.3 | 14.3 | GO:0016272 | prefoldin complex(GO:0016272) |
1.3 | 3.9 | GO:0033186 | CAF-1 complex(GO:0033186) |
1.3 | 38.8 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
1.3 | 3.9 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
1.3 | 7.7 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
1.3 | 22.8 | GO:0097539 | ciliary transition fiber(GO:0097539) |
1.3 | 12.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.2 | 3.7 | GO:0032389 | MutLalpha complex(GO:0032389) |
1.2 | 7.4 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
1.2 | 6.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
1.2 | 15.8 | GO:0001673 | male germ cell nucleus(GO:0001673) |
1.2 | 6.0 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.2 | 8.4 | GO:0098536 | deuterosome(GO:0098536) |
1.2 | 7.1 | GO:0005638 | lamin filament(GO:0005638) |
1.2 | 4.7 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
1.2 | 19.7 | GO:0090543 | Flemming body(GO:0090543) |
1.1 | 1.1 | GO:1902737 | dendritic filopodium(GO:1902737) |
1.1 | 6.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.1 | 17.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.1 | 4.5 | GO:0032021 | NELF complex(GO:0032021) |
1.1 | 11.3 | GO:0034464 | BBSome(GO:0034464) |
1.1 | 16.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
1.1 | 21.4 | GO:0032039 | integrator complex(GO:0032039) |
1.1 | 13.3 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
1.1 | 26.5 | GO:0000145 | exocyst(GO:0000145) |
1.1 | 12.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
1.1 | 9.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
1.1 | 3.2 | GO:1990622 | CHOP-C/EBP complex(GO:0036488) CHOP-ATF3 complex(GO:1990622) |
1.1 | 22.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
1.0 | 14.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
1.0 | 3.1 | GO:0043219 | lateral loop(GO:0043219) |
1.0 | 16.3 | GO:0005876 | spindle microtubule(GO:0005876) |
1.0 | 17.2 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
1.0 | 3.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.0 | 17.2 | GO:0000346 | transcription export complex(GO:0000346) |
1.0 | 4.0 | GO:1990037 | Lewy body core(GO:1990037) |
1.0 | 8.0 | GO:0070847 | core mediator complex(GO:0070847) |
1.0 | 62.8 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
1.0 | 2.9 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
1.0 | 33.0 | GO:0008305 | integrin complex(GO:0008305) |
1.0 | 3.9 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.9 | 1.9 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.9 | 34.8 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.9 | 11.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.9 | 8.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.9 | 1.8 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.9 | 12.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.9 | 6.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.9 | 3.5 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
0.9 | 8.7 | GO:0032009 | early phagosome(GO:0032009) |
0.8 | 14.8 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.8 | 23.3 | GO:0015030 | Cajal body(GO:0015030) |
0.8 | 4.0 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.8 | 13.8 | GO:0036038 | MKS complex(GO:0036038) |
0.8 | 1.5 | GO:0016342 | catenin complex(GO:0016342) |
0.8 | 9.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.8 | 2.3 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.7 | 15.7 | GO:0000242 | pericentriolar material(GO:0000242) |
0.7 | 3.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.7 | 8.9 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.7 | 5.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.7 | 2.2 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
0.7 | 7.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.7 | 22.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.7 | 8.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.7 | 11.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.7 | 7.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.7 | 11.9 | GO:0016600 | flotillin complex(GO:0016600) |
0.7 | 14.5 | GO:0031527 | filopodium membrane(GO:0031527) |
0.7 | 3.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.7 | 6.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.7 | 47.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.7 | 9.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.7 | 75.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.6 | 3.9 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.6 | 0.6 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.6 | 4.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.6 | 1.3 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.6 | 2.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.6 | 2.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.6 | 3.0 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.6 | 3.0 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.6 | 20.5 | GO:0016592 | mediator complex(GO:0016592) |
0.6 | 5.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.6 | 2.3 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.6 | 10.7 | GO:0005861 | troponin complex(GO:0005861) |
0.6 | 2.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.6 | 6.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.5 | 2.2 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.5 | 37.8 | GO:0000776 | kinetochore(GO:0000776) |
0.5 | 84.9 | GO:0001650 | fibrillar center(GO:0001650) |
0.5 | 1.6 | GO:0036398 | TCR signalosome(GO:0036398) |
0.5 | 4.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.5 | 3.7 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.5 | 15.1 | GO:0001741 | XY body(GO:0001741) |
0.5 | 4.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.5 | 6.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.5 | 8.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.5 | 2.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.5 | 41.5 | GO:0000922 | spindle pole(GO:0000922) |
0.5 | 2.5 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.5 | 4.5 | GO:0045298 | tubulin complex(GO:0045298) |
0.5 | 4.5 | GO:0032584 | growth cone membrane(GO:0032584) |
0.5 | 66.6 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.5 | 9.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.5 | 2.9 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.5 | 22.4 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.5 | 21.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.5 | 4.7 | GO:0044754 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
0.5 | 14.6 | GO:0097228 | sperm principal piece(GO:0097228) |
0.5 | 7.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.5 | 7.5 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.5 | 1.9 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.5 | 1.9 | GO:1990032 | parallel fiber(GO:1990032) |
0.5 | 2.8 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.5 | 0.9 | GO:0001652 | granular component(GO:0001652) |
0.4 | 3.1 | GO:0071914 | prominosome(GO:0071914) |
0.4 | 0.9 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.4 | 6.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.4 | 5.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 8.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.4 | 112.8 | GO:0031965 | nuclear membrane(GO:0031965) |
0.4 | 1.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 1.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.4 | 70.3 | GO:0001726 | ruffle(GO:0001726) |
0.4 | 8.8 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.4 | 5.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.4 | 1.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.4 | 4.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 1.9 | GO:0071439 | clathrin complex(GO:0071439) |
0.4 | 120.3 | GO:0016607 | nuclear speck(GO:0016607) |
0.4 | 1.1 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.4 | 1.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.4 | 0.7 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.4 | 1.1 | GO:0060187 | cell pole(GO:0060187) |
0.4 | 4.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 2.9 | GO:0033010 | paranodal junction(GO:0033010) |
0.4 | 2.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.4 | 8.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.4 | 8.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.3 | 1.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 14.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 1.7 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.3 | 4.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.3 | 8.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.3 | 2.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.3 | 1.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.3 | 0.6 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.3 | 2.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 1.6 | GO:0031251 | PAN complex(GO:0031251) |
0.3 | 11.1 | GO:0005819 | spindle(GO:0005819) |
0.3 | 0.6 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.3 | 0.6 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 6.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 22.6 | GO:0005814 | centriole(GO:0005814) |
0.3 | 3.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 3.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 19.7 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.3 | 2.8 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.3 | 6.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.3 | 3.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 2.8 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 10.3 | GO:0043034 | costamere(GO:0043034) |
0.3 | 1.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 5.4 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.3 | 6.2 | GO:0031902 | late endosome membrane(GO:0031902) |
0.3 | 10.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 73.4 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.3 | 0.8 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 1.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 145.7 | GO:0005730 | nucleolus(GO:0005730) |
0.2 | 3.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 2.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 19.3 | GO:0005938 | cell cortex(GO:0005938) |
0.2 | 0.2 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 1.9 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 77.6 | GO:0005813 | centrosome(GO:0005813) |
0.2 | 27.0 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.2 | 0.5 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) extrinsic component of postsynaptic membrane(GO:0098890) |
0.2 | 6.3 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.2 | 0.6 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 31.2 | GO:0030027 | lamellipodium(GO:0030027) |
0.2 | 1.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 7.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 0.4 | GO:0098835 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
0.2 | 11.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 4.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 5.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 2.2 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 1.8 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.7 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 0.7 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 1.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.2 | 1.7 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 3.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 3.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 1.6 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.2 | 4.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 1.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 0.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 3.7 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 5.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 0.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 1.8 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.2 | 19.1 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 3.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 3.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 3.4 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 43.9 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 5.4 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 3.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.4 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 0.7 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 7.2 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.7 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 4.9 | GO:0031248 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.1 | 3.7 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 10.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.4 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.1 | 0.8 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 5.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 7.0 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.4 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 2.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.1 | GO:0005757 | mitochondrial permeability transition pore complex(GO:0005757) |
0.1 | 0.9 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 12.5 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 1.6 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 0.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 7.9 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.2 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 3.9 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 0.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.4 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 4.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.2 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.1 | 1.6 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 1.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.3 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.0 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.1 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.0 | 0.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.2 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 0.1 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.0 | 0.5 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.0 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.0 | 0.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.2 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.0 | 2.7 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.5 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.0 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.1 | 39.3 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
11.4 | 34.2 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
10.9 | 65.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
9.6 | 76.7 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
8.8 | 35.0 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
7.6 | 37.9 | GO:0019767 | IgE receptor activity(GO:0019767) |
7.3 | 7.3 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
7.1 | 28.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
6.8 | 34.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
6.5 | 19.4 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
6.2 | 30.8 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
6.0 | 17.9 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
5.8 | 17.5 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
5.8 | 17.4 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
5.8 | 29.0 | GO:0030621 | U4 snRNA binding(GO:0030621) |
5.8 | 23.2 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
5.7 | 17.0 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
5.7 | 62.2 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
5.6 | 33.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
5.5 | 32.9 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
5.4 | 16.1 | GO:0003896 | DNA primase activity(GO:0003896) |
5.3 | 16.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
5.3 | 26.6 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
5.3 | 89.6 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
5.2 | 21.0 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
5.2 | 36.3 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
5.2 | 46.6 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
5.2 | 15.5 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
5.0 | 29.7 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
4.9 | 68.6 | GO:0070990 | snRNP binding(GO:0070990) |
4.9 | 14.6 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
4.8 | 38.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
4.7 | 14.2 | GO:0070138 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
4.6 | 36.5 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
4.4 | 44.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
4.4 | 17.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
4.2 | 42.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
4.0 | 12.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
4.0 | 20.1 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
4.0 | 12.0 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
3.9 | 50.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
3.8 | 11.3 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
3.7 | 14.8 | GO:0043532 | angiostatin binding(GO:0043532) |
3.6 | 43.6 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
3.6 | 21.8 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
3.4 | 20.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
3.4 | 30.7 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
3.4 | 10.1 | GO:0035500 | MH2 domain binding(GO:0035500) |
3.4 | 13.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
3.3 | 29.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
3.2 | 22.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
3.1 | 9.2 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
3.0 | 21.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
3.0 | 12.0 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
3.0 | 26.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.9 | 35.0 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
2.9 | 78.6 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
2.9 | 11.5 | GO:0032093 | SAM domain binding(GO:0032093) |
2.9 | 28.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
2.9 | 34.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
2.9 | 17.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
2.7 | 10.9 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
2.7 | 8.1 | GO:0042602 | riboflavin reductase (NADPH) activity(GO:0042602) |
2.7 | 10.7 | GO:0072354 | histone kinase activity (H3-T3 specific)(GO:0072354) |
2.6 | 7.9 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
2.6 | 13.1 | GO:0042610 | CD8 receptor binding(GO:0042610) |
2.6 | 15.7 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
2.6 | 25.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
2.5 | 33.0 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
2.5 | 25.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
2.5 | 15.0 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
2.5 | 12.5 | GO:0098809 | nitrite reductase activity(GO:0098809) |
2.5 | 24.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
2.5 | 47.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
2.4 | 17.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
2.4 | 4.9 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
2.4 | 7.3 | GO:0002055 | adenine binding(GO:0002055) adenine phosphoribosyltransferase activity(GO:0003999) |
2.4 | 12.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
2.4 | 7.1 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
2.3 | 28.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
2.3 | 32.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
2.3 | 9.3 | GO:0000010 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
2.3 | 46.0 | GO:0015643 | toxic substance binding(GO:0015643) |
2.3 | 13.6 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
2.3 | 4.5 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
2.2 | 17.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
2.2 | 13.4 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
2.2 | 24.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
2.2 | 6.6 | GO:0098808 | mRNA cap binding(GO:0098808) |
2.2 | 8.8 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
2.2 | 8.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
2.2 | 21.7 | GO:0050733 | RS domain binding(GO:0050733) |
2.1 | 12.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
2.1 | 6.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
2.1 | 14.8 | GO:0043515 | kinetochore binding(GO:0043515) |
2.1 | 10.5 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
2.1 | 8.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
2.1 | 12.6 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
2.0 | 18.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
2.0 | 8.1 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
2.0 | 18.2 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
2.0 | 10.0 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
2.0 | 115.1 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
2.0 | 65.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
2.0 | 11.9 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
2.0 | 4.0 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
2.0 | 35.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
2.0 | 2.0 | GO:0071253 | connexin binding(GO:0071253) |
1.9 | 336.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
1.9 | 5.8 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
1.9 | 7.7 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
1.9 | 11.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.9 | 7.6 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
1.9 | 7.5 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
1.9 | 13.0 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
1.8 | 9.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.8 | 9.2 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
1.8 | 5.5 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
1.8 | 10.9 | GO:0048495 | Roundabout binding(GO:0048495) |
1.8 | 9.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.8 | 18.1 | GO:0004064 | arylesterase activity(GO:0004064) |
1.8 | 21.7 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
1.8 | 5.4 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
1.8 | 26.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
1.8 | 17.8 | GO:0030911 | TPR domain binding(GO:0030911) |
1.8 | 12.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
1.8 | 10.6 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
1.8 | 7.0 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
1.8 | 7.0 | GO:0036310 | annealing helicase activity(GO:0036310) |
1.7 | 12.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
1.7 | 66.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
1.7 | 19.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.7 | 3.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.7 | 24.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.7 | 5.1 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
1.7 | 26.8 | GO:0035174 | histone serine kinase activity(GO:0035174) |
1.6 | 3.2 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
1.6 | 4.8 | GO:0070401 | NADP+ binding(GO:0070401) |
1.6 | 12.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.6 | 1.6 | GO:0048256 | flap endonuclease activity(GO:0048256) |
1.5 | 9.3 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
1.5 | 21.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
1.5 | 38.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.5 | 13.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.5 | 28.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
1.5 | 21.0 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
1.5 | 41.6 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
1.5 | 4.5 | GO:0001096 | TFIIF-class transcription factor binding(GO:0001096) |
1.5 | 46.0 | GO:0043274 | phospholipase binding(GO:0043274) |
1.5 | 10.3 | GO:0015266 | protein channel activity(GO:0015266) |
1.5 | 4.4 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
1.5 | 13.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.5 | 23.5 | GO:0005522 | profilin binding(GO:0005522) |
1.5 | 14.6 | GO:0033691 | sialic acid binding(GO:0033691) |
1.5 | 17.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
1.4 | 4.3 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
1.4 | 4.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
1.4 | 21.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
1.4 | 4.3 | GO:0004350 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
1.4 | 69.5 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
1.4 | 91.2 | GO:0031491 | nucleosome binding(GO:0031491) |
1.4 | 4.2 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
1.4 | 29.3 | GO:0008143 | poly(A) binding(GO:0008143) |
1.4 | 5.5 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
1.4 | 4.1 | GO:0018169 | ribosomal S6-glutamic acid ligase activity(GO:0018169) |
1.4 | 24.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.4 | 6.9 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.4 | 29.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.4 | 1.4 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
1.4 | 4.1 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
1.3 | 18.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
1.3 | 17.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
1.3 | 19.9 | GO:0030274 | LIM domain binding(GO:0030274) |
1.3 | 8.0 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
1.3 | 90.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
1.3 | 10.5 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
1.3 | 3.9 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
1.3 | 5.2 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
1.3 | 1.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
1.3 | 2.6 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
1.3 | 5.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.3 | 6.4 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
1.3 | 7.6 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
1.3 | 10.1 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.3 | 13.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.3 | 3.8 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.3 | 3.8 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
1.2 | 8.7 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
1.2 | 7.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
1.2 | 3.7 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) interleukin-3 binding(GO:0019978) |
1.2 | 4.9 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
1.2 | 7.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.2 | 19.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.2 | 6.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
1.2 | 2.4 | GO:0071723 | lipopeptide binding(GO:0071723) |
1.2 | 4.8 | GO:0031013 | troponin I binding(GO:0031013) |
1.2 | 3.6 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
1.2 | 4.8 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
1.2 | 3.5 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
1.2 | 7.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
1.2 | 70.4 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
1.1 | 5.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.1 | 2.3 | GO:0036004 | GAF domain binding(GO:0036004) |
1.1 | 10.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
1.1 | 4.5 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.1 | 4.5 | GO:0051435 | BH4 domain binding(GO:0051435) |
1.1 | 7.8 | GO:0004849 | uridine kinase activity(GO:0004849) |
1.1 | 3.3 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
1.1 | 3.3 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
1.1 | 4.4 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
1.1 | 66.5 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
1.1 | 15.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.1 | 24.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
1.1 | 40.8 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
1.1 | 9.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
1.1 | 12.6 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
1.1 | 56.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
1.0 | 4.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.0 | 5.1 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
1.0 | 3.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
1.0 | 8.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.0 | 3.0 | GO:0001729 | ceramide kinase activity(GO:0001729) |
1.0 | 3.0 | GO:0004962 | endothelin receptor activity(GO:0004962) |
1.0 | 3.0 | GO:0034188 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
1.0 | 3.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
1.0 | 6.9 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
1.0 | 7.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
1.0 | 3.9 | GO:0008494 | translation activator activity(GO:0008494) |
1.0 | 57.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
1.0 | 13.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
1.0 | 3.8 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
1.0 | 23.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
1.0 | 9.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.0 | 4.8 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
1.0 | 2.9 | GO:0019959 | interleukin-8 binding(GO:0019959) |
1.0 | 4.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.9 | 2.8 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.9 | 1.9 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.9 | 24.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.9 | 1.9 | GO:0097617 | annealing activity(GO:0097617) |
0.9 | 1.8 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
0.9 | 49.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.9 | 1.8 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.9 | 2.7 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.9 | 3.6 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.9 | 66.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.9 | 6.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.9 | 4.5 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.9 | 8.9 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.9 | 11.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.9 | 4.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.9 | 6.2 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.9 | 129.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.9 | 4.4 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.9 | 5.3 | GO:0034618 | arginine binding(GO:0034618) |
0.9 | 10.4 | GO:0008061 | chitin binding(GO:0008061) |
0.9 | 0.9 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.9 | 1.7 | GO:0002135 | CTP binding(GO:0002135) |
0.9 | 2.6 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.9 | 1.7 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.9 | 93.7 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.9 | 2.6 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.9 | 19.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.8 | 5.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.8 | 11.0 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.8 | 5.9 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.8 | 6.8 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.8 | 6.7 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.8 | 15.9 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.8 | 5.0 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.8 | 47.4 | GO:0019209 | kinase activator activity(GO:0019209) |
0.8 | 1.6 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.8 | 12.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.8 | 3.3 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.8 | 0.8 | GO:0042497 | triacyl lipopeptide binding(GO:0042497) |
0.8 | 3.3 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.8 | 4.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.8 | 4.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.8 | 2.4 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.8 | 8.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.8 | 4.0 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.8 | 3.2 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.8 | 6.4 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.8 | 4.8 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.8 | 23.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.8 | 7.9 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.8 | 4.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.8 | 4.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.8 | 1.6 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.8 | 2.3 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.8 | 3.9 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.8 | 3.9 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.8 | 33.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.8 | 7.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.8 | 2.3 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
0.8 | 3.8 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.8 | 50.6 | GO:0004601 | peroxidase activity(GO:0004601) |
0.8 | 3.0 | GO:0031208 | POZ domain binding(GO:0031208) |
0.8 | 15.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.7 | 145.0 | GO:0042393 | histone binding(GO:0042393) |
0.7 | 1.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.7 | 0.7 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.7 | 3.0 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.7 | 28.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.7 | 6.6 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.7 | 11.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.7 | 18.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.7 | 0.7 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.7 | 2.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.7 | 6.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.7 | 2.1 | GO:0016872 | inositol-3-phosphate synthase activity(GO:0004512) intramolecular lyase activity(GO:0016872) |
0.7 | 19.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.7 | 5.6 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.7 | 2.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.7 | 2.1 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.7 | 2.8 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.7 | 10.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.7 | 2.8 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.7 | 2.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.7 | 10.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.7 | 17.0 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.7 | 4.7 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.7 | 4.6 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.7 | 5.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.7 | 2.6 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.7 | 44.9 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.6 | 2.5 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.6 | 2.5 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.6 | 5.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.6 | 5.7 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.6 | 2.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.6 | 2.5 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.6 | 3.7 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.6 | 1.9 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.6 | 230.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.6 | 1.8 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.6 | 17.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.6 | 1.8 | GO:0047291 | lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
0.6 | 2.9 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.6 | 9.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.6 | 1.2 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.6 | 6.9 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.6 | 5.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.6 | 3.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.6 | 1.7 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.6 | 0.6 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.6 | 3.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.6 | 1.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.6 | 3.4 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.6 | 4.5 | GO:0052655 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.6 | 3.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.6 | 21.0 | GO:0002039 | p53 binding(GO:0002039) |
0.6 | 18.2 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.6 | 2.2 | GO:0071796 | K6-linked polyubiquitin binding(GO:0071796) |
0.5 | 4.9 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.5 | 6.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.5 | 13.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.5 | 1.1 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.5 | 2.1 | GO:0019961 | interferon binding(GO:0019961) |
0.5 | 18.7 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.5 | 4.3 | GO:0019956 | chemokine binding(GO:0019956) |
0.5 | 8.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.5 | 6.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.5 | 2.6 | GO:1990188 | euchromatin binding(GO:1990188) |
0.5 | 4.7 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.5 | 2.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.5 | 3.1 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.5 | 2.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.5 | 2.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.5 | 10.9 | GO:0005521 | lamin binding(GO:0005521) |
0.5 | 3.1 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.5 | 1.0 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.5 | 8.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.5 | 2.0 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.5 | 6.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.5 | 1.5 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.5 | 20.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.5 | 1.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.5 | 3.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.5 | 1.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.5 | 2.5 | GO:0089720 | caspase binding(GO:0089720) |
0.5 | 7.5 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.5 | 1.5 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.5 | 2.0 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.5 | 7.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.5 | 9.4 | GO:0070840 | dynein complex binding(GO:0070840) |
0.5 | 18.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.5 | 1.5 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.5 | 1.9 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.5 | 3.9 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.5 | 1.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.5 | 28.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.5 | 1.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.5 | 1.9 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.5 | 1.9 | GO:0070976 | TIR domain binding(GO:0070976) |
0.5 | 2.3 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.5 | 9.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.5 | 2.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.5 | 45.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.4 | 0.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 2.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.4 | 3.1 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.4 | 0.9 | GO:0097001 | ceramide binding(GO:0097001) |
0.4 | 2.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 1.7 | GO:0045183 | translation factor activity, non-nucleic acid binding(GO:0045183) |
0.4 | 1.3 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.4 | 0.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.4 | 6.8 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.4 | 0.8 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.4 | 1.7 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.4 | 1.2 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.4 | 1.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.4 | 8.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.4 | 12.4 | GO:0004386 | helicase activity(GO:0004386) |
0.4 | 0.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.4 | 12.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 2.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.4 | 12.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.4 | 0.8 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.4 | 3.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 9.9 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.4 | 1.1 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.4 | 138.0 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.4 | 2.6 | GO:0019808 | polyamine binding(GO:0019808) |
0.4 | 21.2 | GO:0004527 | exonuclease activity(GO:0004527) |
0.4 | 0.4 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.4 | 63.3 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.4 | 0.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.4 | 10.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.4 | 2.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.4 | 1.8 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.4 | 5.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.4 | 5.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 1.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.4 | 3.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.4 | 5.1 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.4 | 5.4 | GO:0016918 | retinal binding(GO:0016918) |
0.4 | 9.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.4 | 20.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.4 | 2.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.4 | 1.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.4 | 11.5 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.4 | 18.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.4 | 1.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.4 | 33.0 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.3 | 5.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 0.7 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.3 | 12.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.3 | 33.6 | GO:0005178 | integrin binding(GO:0005178) |
0.3 | 378.5 | GO:0003723 | RNA binding(GO:0003723) |
0.3 | 7.9 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.3 | 9.5 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.3 | 2.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.3 | 2.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 1.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 0.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.3 | 1.0 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.3 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 1.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.3 | 1.2 | GO:0050436 | microfibril binding(GO:0050436) |
0.3 | 9.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 1.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 47.9 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.3 | 3.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 9.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 0.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 1.6 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.3 | 9.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 1.5 | GO:0000150 | recombinase activity(GO:0000150) |
0.3 | 2.0 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 0.5 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.3 | 9.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 0.7 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.2 | 0.7 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 1.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 1.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 6.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 1.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.2 | 2.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 0.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 11.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 3.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 0.7 | GO:0032394 | MHC class Ib receptor activity(GO:0032394) |
0.2 | 0.5 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.2 | 0.5 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 13.0 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 3.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 27.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 2.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 0.7 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.2 | 89.6 | GO:0003779 | actin binding(GO:0003779) |
0.2 | 3.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.6 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.2 | 2.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 0.9 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.2 | 1.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 3.6 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.2 | 2.3 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.2 | 1.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 0.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.8 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.2 | 1.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 8.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 1.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 19.4 | GO:0000149 | SNARE binding(GO:0000149) |
0.2 | 3.8 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 0.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 0.7 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 4.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 5.6 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.2 | 0.7 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 0.7 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.2 | 4.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.9 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.2 | 0.5 | GO:0048185 | activin binding(GO:0048185) |
0.2 | 0.5 | GO:0004134 | glycogen debranching enzyme activity(GO:0004133) 4-alpha-glucanotransferase activity(GO:0004134) amylo-alpha-1,6-glucosidase activity(GO:0004135) |
0.2 | 2.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 0.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.2 | 0.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 0.6 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.7 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.1 | 1.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 3.1 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 6.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 4.6 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 7.8 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 1.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 2.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 1.0 | GO:0015265 | urea channel activity(GO:0015265) |
0.1 | 10.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 3.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 1.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 1.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 5.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 2.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 1.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 1.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 12.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 1.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 8.2 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 1.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 1.3 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.6 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 1.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.3 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.1 | 0.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.8 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.7 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 4.6 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.1 | 0.3 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.1 | 0.8 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 1.4 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 1.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 2.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 1.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 1.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 1.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 1.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 3.0 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 7.6 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.2 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.1 | 0.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.4 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.1 | 2.8 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.1 | 0.9 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.9 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.6 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.2 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.1 | 0.2 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.1 | 2.9 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.9 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.1 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.0 | 0.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 2.3 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.4 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.2 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 8.9 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 1.1 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.0 | 1.2 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 201.7 | PID AURORA B PATHWAY | Aurora B signaling |
2.7 | 114.7 | PID AURORA A PATHWAY | Aurora A signaling |
2.6 | 142.1 | PID ATR PATHWAY | ATR signaling pathway |
2.4 | 14.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
2.3 | 81.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
2.3 | 52.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
2.0 | 46.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
2.0 | 85.9 | PID PLK1 PATHWAY | PLK1 signaling events |
1.9 | 3.7 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
1.9 | 61.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.8 | 56.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.7 | 10.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
1.7 | 26.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.7 | 87.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
1.6 | 205.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
1.6 | 80.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
1.5 | 16.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
1.5 | 115.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.4 | 42.0 | PID MYC PATHWAY | C-MYC pathway |
1.4 | 1.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.4 | 2.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.4 | 40.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.3 | 15.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.3 | 42.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.3 | 2.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.2 | 77.3 | PID BCR 5PATHWAY | BCR signaling pathway |
1.2 | 44.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.2 | 25.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.2 | 89.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
1.0 | 22.0 | PID ARF 3PATHWAY | Arf1 pathway |
1.0 | 35.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
1.0 | 26.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
1.0 | 24.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
1.0 | 48.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.9 | 11.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.9 | 86.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.9 | 48.8 | PID E2F PATHWAY | E2F transcription factor network |
0.9 | 36.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.9 | 20.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.9 | 23.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.9 | 35.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.8 | 4.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.8 | 18.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.8 | 14.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.8 | 31.9 | PID INSULIN PATHWAY | Insulin Pathway |
0.8 | 14.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.8 | 23.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.7 | 23.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.7 | 13.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.7 | 28.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.7 | 61.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.7 | 17.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.7 | 20.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.7 | 8.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.6 | 7.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.6 | 1.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.6 | 5.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.6 | 8.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.5 | 2.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.5 | 3.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.5 | 14.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.5 | 4.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.5 | 33.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.5 | 15.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.5 | 16.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.5 | 13.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.5 | 3.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.5 | 32.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.5 | 1.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.5 | 4.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.5 | 16.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.4 | 19.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.4 | 22.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.4 | 13.5 | PID P73PATHWAY | p73 transcription factor network |
0.4 | 4.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.4 | 6.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.4 | 3.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 17.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.4 | 9.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.4 | 8.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.4 | 1.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.3 | 39.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.3 | 11.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 10.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 7.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.3 | 13.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.3 | 7.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.3 | 5.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 2.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 1.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 12.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 3.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.3 | 1.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 1.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 4.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 7.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 16.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 3.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 1.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 36.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 1.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 8.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 0.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 5.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 2.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 5.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 1.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 2.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 9.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.3 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.3 | 132.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
6.1 | 42.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
5.8 | 92.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
5.7 | 74.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
5.2 | 108.3 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
4.7 | 579.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
4.4 | 17.8 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
4.1 | 69.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
3.7 | 81.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
3.2 | 63.7 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
3.1 | 98.7 | REACTOME KINESINS | Genes involved in Kinesins |
3.0 | 68.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
3.0 | 89.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
2.9 | 23.6 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
2.8 | 168.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
2.8 | 47.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
2.7 | 19.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
2.7 | 48.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
2.7 | 55.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
2.5 | 27.8 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
2.4 | 116.4 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
2.4 | 42.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
2.1 | 84.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
2.0 | 32.5 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
2.0 | 26.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
2.0 | 6.0 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
1.9 | 11.7 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
1.9 | 22.7 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
1.9 | 3.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.8 | 22.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.8 | 44.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.8 | 39.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
1.7 | 19.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.7 | 11.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
1.6 | 13.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
1.6 | 45.8 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
1.6 | 140.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.6 | 110.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
1.5 | 38.6 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
1.5 | 86.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
1.5 | 66.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.5 | 24.1 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
1.4 | 17.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.4 | 66.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
1.3 | 33.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.3 | 41.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
1.3 | 38.4 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
1.3 | 29.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.3 | 11.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
1.2 | 18.6 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
1.2 | 28.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
1.2 | 3.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
1.2 | 8.6 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
1.2 | 17.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
1.2 | 80.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.2 | 38.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.2 | 6.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
1.2 | 19.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
1.2 | 2.4 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
1.2 | 25.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
1.1 | 34.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
1.1 | 48.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.1 | 15.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
1.1 | 12.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.1 | 30.8 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
1.1 | 35.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.0 | 67.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
1.0 | 1.0 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
1.0 | 19.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.0 | 9.3 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
1.0 | 11.3 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
1.0 | 8.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
1.0 | 6.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
1.0 | 45.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
1.0 | 11.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.0 | 50.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.9 | 1.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.9 | 3.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.8 | 6.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.8 | 14.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.8 | 0.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.8 | 8.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.8 | 6.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.8 | 4.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.8 | 18.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.8 | 20.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.8 | 25.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.8 | 17.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.8 | 3.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.7 | 9.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.7 | 20.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.7 | 5.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.7 | 9.9 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.7 | 25.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.6 | 11.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.6 | 9.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.6 | 11.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.6 | 10.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.6 | 11.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.6 | 1.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.6 | 15.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.6 | 14.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.6 | 4.3 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.6 | 6.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.6 | 38.3 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.6 | 7.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.6 | 9.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.6 | 28.3 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.6 | 122.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.6 | 3.9 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.6 | 11.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.5 | 28.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.5 | 4.8 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.5 | 20.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.5 | 2.9 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.5 | 106.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.4 | 3.9 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.4 | 7.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.4 | 8.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.4 | 9.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.4 | 6.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.4 | 6.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.4 | 1.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.4 | 4.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.4 | 4.4 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.4 | 2.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 16.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.3 | 19.6 | REACTOME TRANSLATION | Genes involved in Translation |
0.3 | 1.4 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.3 | 9.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 3.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 8.3 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.3 | 4.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.3 | 2.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.3 | 4.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.3 | 6.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.3 | 10.0 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.3 | 2.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 7.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.3 | 14.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.3 | 8.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.3 | 2.7 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.3 | 1.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 14.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 2.2 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.2 | 3.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 7.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 2.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 3.9 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 9.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 2.8 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 0.6 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.2 | 13.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 0.2 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.2 | 3.9 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.2 | 2.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 6.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 2.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 1.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 1.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 7.2 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.2 | 3.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 14.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 4.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 2.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 3.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 3.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 2.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 5.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 6.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.5 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 2.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 2.0 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 0.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.7 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |